TWI483742B - Method of treating cells in vitro with composition containing extract of peony root cortex and application thereof - Google Patents

Method of treating cells in vitro with composition containing extract of peony root cortex and application thereof Download PDF

Info

Publication number
TWI483742B
TWI483742B TW101137159A TW101137159A TWI483742B TW I483742 B TWI483742 B TW I483742B TW 101137159 A TW101137159 A TW 101137159A TW 101137159 A TW101137159 A TW 101137159A TW I483742 B TWI483742 B TW I483742B
Authority
TW
Taiwan
Prior art keywords
dna
cells
peony
uvb
cell
Prior art date
Application number
TW101137159A
Other languages
Chinese (zh)
Other versions
TW201414502A (en
Inventor
Hsiouyu Ding
Chiahua Liang
Tzunghan Chou
Original Assignee
Univ Chia Nan Pharm & Sciency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Chia Nan Pharm & Sciency filed Critical Univ Chia Nan Pharm & Sciency
Priority to TW101137159A priority Critical patent/TWI483742B/en
Publication of TW201414502A publication Critical patent/TW201414502A/en
Application granted granted Critical
Publication of TWI483742B publication Critical patent/TWI483742B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)

Description

利用含有牡丹皮萃取物之組成物於體外處理細胞之方法及其應用Method for treating cells in vitro by using composition containing peony bark extract and application thereof

本發明是有關於一種牡丹皮萃取物及其製造方法,特別是有關於一種兼具DNA修復與抑制黑色素生成的複數種生物活性之牡丹皮萃取物及其製造方法。The present invention relates to a peony bark extract and a method for producing the same, and more particularly to a plurality of biologically active peony bark extracts having both DNA repair and inhibition of melanin production and a method for producing the same.

近年來,由於國民生活水準的提升,使得現代人對於自己的儀容越來越重視。惟臭氧層日漸破壞,使得人們對於美白、淡斑及袪斑相關產品的需求量大增,因而化粧保養品的市場規模逐年擴大。此外,現代人對於健康觀念萌起,為避免因化學成分之化粧保養品傷害皮膚,因此中草藥天然物在保健食品與美容上的應用以普遍受到重視,尤其是將中草藥萃取物應用於化粧品中已成為全球趨勢,亦是目前國內化妝品及生技產業積極開發的重點。In recent years, due to the improvement of the standard of living of the people, modern people have paid more and more attention to their appearance. However, the depletion of the ozone layer has led to an increase in the demand for whitening, blemishes and freckle-related products, and the market size of cosmetic products has expanded year by year. In addition, modern people have a healthy concept, in order to avoid damage to the skin caused by chemical makeup products, the application of Chinese herbal medicines in health foods and beauty has been generally valued, especially the application of Chinese herbal extracts in cosmetics. To become a global trend is also the focus of the active development of the domestic cosmetics and biotechnology industry.

輻射與紫外線照射於生物體會形成光損傷,引起水腫、紅斑、曬斑、細胞凋亡和抑制免疫反應等,使皮膚細胞中的DNA造成光損傷。DNA光損傷為啟動細胞修復系統之首要信號分子,當DNA產生內生性DNA雙股斷裂(DSB)或外生性DNA單股斷裂(SSB)時,會改變DNA結構且導致一連串生理反應機制,使細胞週期停滯並啟動DNA修復機制。Radiation and ultraviolet radiation on the organism can cause photodamage, causing edema, erythema, sunburn, apoptosis, and suppression of immune responses, causing photodamage of DNA in skin cells. DNA photodamage is the primary signaling molecule in the initiation of cell repair systems. When DNA produces endogenous DNA double strand breaks (DSB) or exogenous DNA single strand breaks (SSB), it changes the DNA structure and leads to a cascade of physiological mechanisms that allow cells to The cycle is stagnant and the DNA repair mechanism is initiated.

上述之內生性DNA雙股斷裂(DSB)主要來自於細胞正常生理反應中所形成之甲基化物質(methylating species;MS)和活性氧物質(ROS),引發自由基攻擊細胞、生成細胞 毒性、無法進行修復,DNA雙股斷裂之損傷進行錯誤的修復,引發基因突變與致癌性。主要透過非同源末端接合修復(non-homologous end joining;NHEJ)和同源互換重組(Homologous recombination;HR)之機制進行修復。The above-mentioned endogenous DNA double-strand break (DSB) mainly comes from methylating species (MS) and reactive oxygen species (ROS) formed in normal physiological reactions of cells, which trigger free radicals to attack cells and produce cells. Toxicity, inability to repair, damage to DNA double-strand breaks, erroneous repair, triggering gene mutations and carcinogenicity. Repair is mainly performed by a mechanism of non-homologous end joining (NHEJ) and homologous recombination (HR).

上述之外生性DNA單股斷裂(SSB)則多因環境之紫外線、輻射、空氣、化學物質等外在因子,皆會誘導DNA產生損傷,影響細胞週期停滯、DNA轉錄或轉譯產生突變或斷裂損傷,藉由模板轉換(template switching)、跨損傷修復(translation synthesis;TLS)、配對錯誤修復(mismatch repair;MMR)、鹼基切除修復(base-excision repair;BER)、核甘酸切除修復(nucleotide-excision repair;NER),以修復各種DNA配對錯誤、突變或單股斷裂之損傷。The above-mentioned exogenous DNA single-strand break (SSB) is mostly caused by environmental external ultraviolet, radiation, air, chemical substances and other external factors, which will induce DNA damage, affect cell cycle arrest, DNA transcription or translation to produce mutation or breakage damage. , by template switching, translation synthesis (TLS), mismatch repair (MMR), base-excision repair (BER), nucleotide removal repair (nucleotide- Excision repair; NER) to repair damage to various DNA pairing errors, mutations or single strand breaks.

其次,紫外線能誘導皮膚組織產生黑色素(melanin)且使皮膚顏色變深,而黑色素的生成又與酪胺酸酶(tyrosinase)的活性以及酪胺酸酶相關蛋白-1(tyrosinase-related protein-1;TRP-1;DHICA oxidase)和TRP-2(tyrosinase-related protein-2;TRP-2;DOPA chrometautomerase)有著密不可分的關係。TRP-2可催化多巴色素(dopachrome)轉變為DHICA(5,6-dihydroxy indole carboxylic acid),TRP-1則可催化DHICA的氧化反應。Secondly, ultraviolet light can induce skin tissue to produce melanin and darken the skin color, while melanin production is combined with tyrosinase activity and tyrosinase-related protein-1. ; TRP-1; DHICA oxidase) and TRP-2 (tyrosinase-related protein-2; TRP-2; DOPA chrometautomerase) are inextricably linked. TRP-2 can catalyze the conversion of dopachrome to DHICA (5,6-dihydroxy indole carboxylic acid), while TRP-1 can catalyze the oxidation of DHICA.

目前市面上之美白成分,例如:維生素C(vitamin C)、對苯二酚(hydroquinone;HQ)、杜鵑花酸(acelaic acid)及熊果素(arbutin)等,其美白作用雖顯著,但是部分美白劑係藉由直接破壞黑色素細胞而達成美白功效,仍有細胞毒殺性的缺點。因此,仍有必要尋找具有細胞安全性之美白成分。Currently, whitening ingredients on the market, such as vitamin C, hydroquinone (HQ), acelaic acid and arbutin, although the whitening effect is significant, but some whitening agents It achieves whitening effect by directly destroying melanocytes, and still has the disadvantage of cytotoxicity. Therefore, it is still necessary to find a whitening ingredient with cell safety.

再者,傳統中草藥針對女性美容保養,多為一些補氣活血、調整體質的溫補藥物,雖有少許單、複方直接使用於皮膚美白、除痘、消炎等用途,但是對於中草藥萃取物中之有效成分之機制分析與其於化粧品中之配方設計,仍不夠清楚。如能從傳統中草藥中開發出低劑量、高效能之美白與抗氧化之化粧保養產品,將有助於提升化粧品科技產業。In addition, the traditional Chinese herbal medicine for women's beauty care, mostly for qi and blood circulation, adjust the body of warming medicine, although there are a few single, the compound is directly used in skin whitening, acne, anti-inflammatory, etc., but for Chinese herbal extracts The mechanism analysis of active ingredients and their formulation in cosmetics are still not clear enough. The development of low-dose, high-performance whitening and anti-oxidant makeup maintenance products from traditional Chinese herbal medicines will help to enhance the cosmetics technology industry.

有鑑於此,亟需提出一種DNA修復與抑制黑色素生成的複數種生物的植物性物質,以期能提供化妝品組合物及/或食品添加物。In view of the above, there is a need to provide a plant material for DNA repair and a plurality of organisms that inhibit melanin production, in order to provide a cosmetic composition and/or a food additive.

因此,本發明之一態樣是在提供一種牡丹皮萃取物用於製備修復DNA與抑制黑色素生成之組成物,其中此牡丹皮萃取物為單萜醣苷(monoterpene glycoside)類化合物,例如牡丹皮苷D(mudanpioside D,或稱b-D-glucopyranoside),其兼具修復DNA與抑制黑色素生成的生物活性,可進一步應用於化妝品組合物及/或食品添加物。Accordingly, one aspect of the present invention provides a composition of a peony bark extract for preparing repair DNA and inhibiting melanin production, wherein the peony bark extract is a monoterpene glycoside compound such as peony saponin. D (mudanpioside D, or bD-glucopyranoside), which has both biological activity for repairing DNA and inhibiting melanin production, can be further applied to cosmetic compositions and/or food additives.

根據本發明之上述態樣,提出一種牡丹皮萃取物用於製備修復DNA與抑制黑色素生成之組成物,此牡丹皮萃取物為如式(I)所示之牡丹皮苷D: According to the above aspect of the present invention, a peony bark extract is prepared for preparing a repair DNA which inhibits melanin production, and the peony bark extract is a peony rind D as shown in the formula (I):

且此組合物具有一有效含量之牡丹皮萃取物,以同時修復DNA與抑制黑色素生成。And the composition has an effective amount of peony bark extract to simultaneously repair DNA and inhibit melanin production.

依據本發明一實施例,上述之組成物為一化妝品組合物及/或一食品添加物。According to an embodiment of the invention, the composition is a cosmetic composition and/or a food additive.

應用本發明之牡丹皮萃取物用於製備修復DNA與抑制黑色素生成之組成物,由於此牡丹皮苷D兼具DNA修復與抑制黑色素生成的生物活性,可應用於化妝品組合物及/或食品添加物。The peony bark extract of the present invention is used for preparing a composition for repairing DNA and inhibiting melanin production, and the peony saponin D can be used for cosmetic composition and/or food addition because of both DNA repair and bioactivity of inhibiting melanin production. Things.

承前所述,本發明提供一種牡丹皮萃取物用於製備修復DNA與抑制黑色素生成之組成物,其係含有有效含量之牡丹皮苷D,以同時修復DNA並抑制黑色素生成。As described above, the present invention provides a composition of the peony bark extract for preparing repair DNA and inhibiting melanin production, which comprises an effective amount of peponin D to simultaneously repair DNA and inhibit melanin production.

本文此處所稱之「牡丹皮」係指毛茛科(Ranunculaceae )芍藥屬(Paeonia )牡丹(Paenoina Suffruticosa )的根皮(root cortex)。牡丹皮是一種中草藥,在中醫上主要用來提供涼血、清熱、活血及散瘀的功能。本發明使用之牡丹皮可採用市售產品,或將牡丹皮利用習知分配萃取及/或管柱分離 步驟萃取而得之牡丹皮苷D(mudanpioside D,或稱b-D-glucopyranoside)。The paper referred to here, "Paeonia" means Ranunculaceae (Ranunculaceae) Paeonia (P aeonia) Peony (Paenoina Suffruticosa) root bark (root cortex). Mudanpi is a kind of Chinese herbal medicine. It is mainly used in traditional Chinese medicine to provide functions of cooling blood, clearing away heat, promoting blood circulation and dispersing phlegm. The peony bark used in the present invention may be a commercially available product, or a mudanpioside D (or bD-glucopyranoside) obtained by extracting peony bark by a conventional dispensing extraction and/or column separation step.

請參閱第1圖,其係繪示習知技術之牡丹皮萃取物之製造方法流程圖,其係參考本案發明人之一於Phytochemistry第41卷第1期頁237-242(1996年)發表標題為「Monoterpene Glycosides FromPaeonia suffruticosa 」一文,以及碩士論文(標題為「牡丹皮之化學成分研究」,1994年),此處一併列為本發明之參考文獻。Referring to Fig. 1, there is shown a flow chart showing a method for producing a peony bark extract of the prior art, which is referred to by the inventor of the present invention in Phytochemistry, Vol. 41, No. 1, pp. 237-242 (1996). The article "Monoterpene Glycosides From Paeonia suffruticosa " and the master's thesis (titled "Study on the Chemical Constituents of Mudanpi", 1994) are hereby incorporated by reference.

簡言之,牡丹皮萃取物之製造方法100可如步驟101所示,首先提供牡丹皮材料。在一個例示中,牡丹皮材料可為乾燥粉末,一般可係於室溫或略低於室溫之溫度下,利用粉碎機打碎牡丹皮而形成牡丹皮乾燥粉末。Briefly, the method 100 of making the peony bark extract can provide the peony bar material as shown in step 101. In an illustration, the peony bark material may be a dry powder, which may be broken at room temperature or slightly below room temperature, and the peony bark is broken by a pulverizer to form a dry powder of peony bark.

接著,如步驟103所示,利用第一有機溶液,例如乙醇溶液,對前述之牡丹皮材料101進行粗萃取步驟,以獲得粗萃物。在一例示中,前述之乙醇溶液之濃度可例如為至少95體積百分比[%(v/v)]。Next, as shown in step 103, the aforementioned peony skin material 101 is subjected to a crude extraction step using a first organic solution, such as an ethanol solution, to obtain a crude extract. In one example, the concentration of the aforementioned ethanol solution may be, for example, at least 95 volume percent [% (v/v)].

在此補充說明的是,本發明所屬技術領域中任何具有通常知識者應可理解,在進行前述粗萃取步驟時,可進一步進行固液分離處理,利用紗布、濾紙、離心或其他方式處理一次或重複數次後,去除牡丹皮材料101之殘渣,並合併所得濾液。It should be further noted that any one of ordinary skill in the art to which the present invention pertains should be able to understand that the solid-liquid separation process may be further performed during the above-mentioned crude extraction step, using gauze, filter paper, centrifugation or other means. After repeating several times, the residue of the peony skin material 101 was removed, and the obtained filtrate was combined.

在前述固液分離處理後,前述濾液更可選擇性進行濃縮步驟,例如利用減壓濃縮法、真空濃縮法等習知方式,去除前述濾液之乙醇溶液,以獲得粗萃物。After the solid-liquid separation treatment, the filtrate may be selectively subjected to a concentration step, and the ethanol solution of the filtrate may be removed by a conventional method such as a vacuum concentration method or a vacuum concentration method to obtain a crude extract.

之後,利用至少一分配萃取步驟以及至少一管柱分離 步驟,以獲得牡丹皮萃取物。本文此處所稱之「至少一分配萃取步驟」,實指利用不同極性的有機溶劑系統對牡丹皮材料進行分配萃取。Thereafter, using at least one partitioning extraction step and at least one column separation Steps to obtain a peony bark extract. As used herein, "at least one partitioning extraction step" refers to the partition extraction of peony bark material using an organic solvent system of different polarity.

申言之,在一實施例中,如步驟105所示,可利用第二有機混合溶液,例如正己烷/甲醇溶液,對上述之粗萃取物進行第一分配萃取步驟,以劃分(partition)出第一有機相以及第二有機相。在一例示中,前述第二有機混合溶液之甲醇為95%(v/v)之甲醇溶液,且第二有機混合溶液之正己烷與甲醇之體積比例如可為1:1。In an embodiment, as shown in step 105, the first extraction extraction step may be performed on the crude extract by using a second organic mixed solution, such as a n-hexane/methanol solution, to partition. The first organic phase and the second organic phase. In one example, the methanol of the second organic mixed solution is a 95% (v/v) methanol solution, and the volume ratio of n-hexane to methanol of the second organic mixed solution may be, for example, 1:1.

在步驟105之後,可選擇性去除前述第一有機相之甲醇。至於去除甲醇之方式,可採用前述獲得粗萃物相同之濃縮步驟或其他習知方式進行,此處不再贅述。After step 105, the methanol of the first organic phase described above can be selectively removed. As for the manner of removing the methanol, the same concentration step as the above-mentioned crude extract can be used or other conventional methods, and details are not described herein.

然後,如步驟107所示,利用第三有機水溶液,例如乙酸乙酯/水溶液,對前述第一有機相進行第二分配萃取步驟,以劃分出第三有機相以及第一水相,其中第三有機相為乙酸乙酯相。在一例示中,前述之第三有機水溶液的乙酸乙酯與水之體積比可例如為1:1。Then, as shown in step 107, the first organic phase is subjected to a second partitioning extraction step using a third organic aqueous solution, such as an ethyl acetate/water solution, to fractionate the third organic phase and the first aqueous phase, wherein the third The organic phase is the ethyl acetate phase. In one example, the volume ratio of ethyl acetate to water of the third organic aqueous solution may be, for example, 1:1.

之後,如步驟109所示,利用第四有機溶液,例如正丁醇,對上述第一水相進行第三分配萃取步驟,以劃分出第四有機相與第二水相。Thereafter, as shown in step 109, a third partitioning extraction step is performed on the first aqueous phase using a fourth organic solution, such as n-butanol, to separate the fourth organic phase from the second aqueous phase.

而後,如步驟111所示,對前述第三有機相進行第一矽膠管柱層析步驟。在一例示中,第一矽膠管柱層析步驟可使用市售矽膠層析管柱並利用第一沖提液進行沖提,其中第一沖提液可例如為氯仿以及氯仿與甲醇之混合液(其中氯仿與甲醇的體積比例如可為97:3),以獲得第一溶離 液與殘留物。Then, as shown in step 111, a first rubber column chromatography step is performed on the third organic phase. In an example, the first cartridge column chromatography step can be performed using a commercially available silicone chromatography column and eluted with a first extract, wherein the first extract can be, for example, chloroform and a mixture of chloroform and methanol. (wherein the volume ratio of chloroform to methanol can be, for example, 97:3) to obtain the first dissolution Liquid and residue.

隨後,如步驟113所示,合併前述殘留物與第四有機相,再進行第二矽膠管柱層析步驟並利用第二沖提液進行沖提,其中第二沖提液可例如為氯仿與甲醇之混合液(其中氯仿與甲醇的體積比例如可為17:3),而第二矽膠管柱層析步驟與第一矽膠管柱層析步驟使用之管柱可相同,以獲得含有牡丹皮萃取物之第二溶離液。在一例示中,上述之牡丹皮萃取物為單萜醣苷類化合物,即如式(I)所示之牡丹皮苷D: Subsequently, as shown in step 113, the residue and the fourth organic phase are combined, and a second rubber column chromatography step is performed and the second extraction liquid is used for the extraction, wherein the second liquid extract may be, for example, chloroform and a mixture of methanol (wherein the volume ratio of chloroform to methanol can be, for example, 17:3), and the second cartridge column chromatography step can be the same as that used for the first cartridge column chromatography step to obtain a corundum skin a second solution of the extract. In one example, the above-mentioned peony bark extract is a monoterpene glycoside compound, ie, pepiside D as shown in formula (I):

在一實施例中,於第二矽膠管柱層析步驟之後,更可選擇性對上述之第二溶離液進行逆相層析管柱分離/HPLC步驟,以純化出牡丹皮苷D。In one embodiment, after the second xylene column chromatography step, the second eluate is selectively subjected to a reverse phase chromatography column separation/HPLC step to purify the peony saponin D.

上述純化所得之牡丹皮苷D經體外試驗證實,兼具DNA修復與抑制黑色素生成的生物活性,因此可應用於化妝品組合物及/或食品添加物。The above-mentioned purified pepiside D has been confirmed by in vitro tests to have both biological activity for DNA repair and inhibition of melanin production, and thus can be applied to cosmetic compositions and/or food additives.

此處所稱之「DNA修復」的生物活性係指上述所得之牡丹皮萃取物可有效促進細胞內的DNA修復,減少細胞在UV照射後引起的傷害,進而提升細胞存活率。在本發明一個例子中,上述所得之牡丹皮苷D經以下實施例證實,可 藉由UV照射後之細胞存活率、彗星試驗等,確實具有修復DNA的生物活性。The biological activity of "DNA repair" as referred to herein means that the above-mentioned peony peel extract can effectively promote DNA repair in cells, reduce damage caused by UV irradiation, and thereby improve cell survival rate. In one example of the present invention, the above-obtained pepiside D is exemplified by the following examples. The cell viability, the comet assay, and the like after UV irradiation do have biological activity for repairing DNA.

此處所稱之「抑制黑色素生成」的生物活性係指上述所得之牡丹皮萃取物可有效抑制酪胺酸酶之活性,進而減少多巴醌(dopaquinone)以及黑色素的生成,進而達到皮膚美白之功效。申言之,造成皮膚色素沈著最主要的因素是由於暴露於紫外光照射,導致黑色素細胞內的黑色素合成,其中酪胺酸酶是催化黑色素合成的主要關鍵酵素。因此,在本發明一個例子中,上述所得之牡丹皮苷D經以下實施例證實,可藉由抑制酪胺酸酶之活性、抑制細胞外與細胞內黑色素含量、向下調控(down-regulate)黑色素生成(melanogenesis)時之相關蛋白質(例如MC1R、MITF、酪胺酸酶、TRP-1、TRP-2等)的表現等,以達到抑制黑色素生成之目的。The biological activity of "inhibiting melanin production" as referred to herein means that the peony skin extract obtained above can effectively inhibit the activity of tyrosinase, thereby reducing the production of dopaquinone and melanin, thereby achieving skin whitening effect. . According to the statement, the most important factor causing skin pigmentation is the melanin synthesis in melanocytes due to exposure to ultraviolet light, which is the main key enzyme that catalyzes the synthesis of melanin. Therefore, in one example of the present invention, the above-obtained pepiside D is exemplified by inhibiting the activity of tyrosinase, inhibiting extracellular and intracellular melanin content, and down-regulate The expression of related proteins (eg, MC1R, MITF, tyrosinase, TRP-1, TRP-2, etc.) during melanogenesis to inhibit melanin production.

值得一提的是,本發明經由體外(in vitro)及體內(in vivo)試驗證實牡丹皮苷D兼具修復DNA與抑制黑色素生成之功效,因此可應用於化妝品組合物及/或食品添加物。舉例而言,本發明所得之牡丹皮苷D應用於化妝品組合物時,其形式可包括但不限於水劑、乳劑、膏劑、粉劑、美白劑、淡斑劑、袪斑劑或上述任意組合之化妝品。此外,本發明所得之牡丹皮苷D應用於食品添加物時,其形式可包括但不限於營養品或保健食品。It is worth mentioning that the present invention proves that puerarin D has both the function of repairing DNA and inhibiting melanin production by in vitro and in vivo tests, and thus can be applied to cosmetic compositions and/or food additives. . For example, when the pepiside D obtained by the present invention is applied to a cosmetic composition, the form thereof may include, but not limited to, a liquid, an emulsion, an ointment, a powder, a whitening agent, a spotting agent, a freckle agent, or any combination thereof. cosmetic. Further, when the pepiside D obtained by the present invention is applied to a food additive, the form thereof may include, but is not limited to, a nutraceutical or a health food.

以下利用數個實施例以說明本發明之應用,然其並非用以限定本發明,本發明技術領域中具有通常知識者,在不脫離本發明之精神和範圍內,當可作各種之更動與潤飾。The following examples are used to illustrate the application of the present invention, and are not intended to limit the present invention. Those skilled in the art can make various changes without departing from the spirit and scope of the present invention. Retouching.

實施例一:牡丹皮萃取物之製備Example 1: Preparation of Cortex Mouth Extract

此實施例係利用第1圖之方法100製造牡丹皮萃取物。首先,如步驟101所示,進行粗萃取步驟,其係利用粉碎機,在室溫或略低於室溫之溫度下,打碎約45.0公斤之牡丹皮材料。This example produces a peony bark extract using the method 100 of Figure 1. First, as shown in step 101, a crude extraction step is carried out by using a pulverizer to break up about 45.0 kg of peony bark material at room temperature or slightly below room temperature.

接著,如步驟103所示,進行粗萃取步驟,其係將打碎之牡丹皮材料浸於95體積百分比之乙醇溶液後,進行固液分離步驟,其係利用紗布、濾紙、離心或其他方式處理一次,或接著利用70體積百分比之乙醇溶液萃取殘渣並重複數次後,去除牡丹皮材料101之殘渣,並合併前述所得的濾液。在固液分離處理後,利用減壓濃縮法去除上述濾液之乙醇溶液後,獲得約6.8公斤牡丹皮之粗萃物。Next, as shown in step 103, a crude extraction step is performed, after the pulverized peony bark material is immersed in a 95 volume percent ethanol solution, and subjected to a solid-liquid separation step, which is treated by gauze, filter paper, centrifugation or the like. After one time, or after extracting the residue with a 70 volume percent ethanol solution and repeating several times, the residue of the peony skin material 101 is removed, and the filtrate obtained as described above is combined. After the solid-liquid separation treatment, the ethanol solution of the above filtrate was removed by a reduced pressure concentration method to obtain a crude extract of about 6.8 kg of peony bark.

之後,如步驟105所示,利用體積比1:1之正己烷/95%(v/v)甲醇溶液對上述粗萃物進行第一分配萃取步驟,以劃分出95%(v/v)甲醇相(約5.09公斤)以及正己烷相(約1.61公斤),其中95%(v/v)甲醇相包含第一萃取物。Thereafter, as shown in step 105, the crude extract is subjected to a first partition extraction step using a volume ratio of 1:1 n-hexane/95% (v/v) methanol solution to fractionate 95% (v/v) methanol. Phase (about 5.09 kg) and n-hexane phase (about 1.61 kg), of which 95% (v/v) methanol phase contains the first extract.

在步驟105之後,可選擇性利用前述獲得粗萃物相同之濃縮步驟或其他習知方式,去除前述95%(v/v)甲醇相之甲醇,以獲得第一萃取物。至於上述濃縮步驟或其他習知方式悉如前述,此處不再贅言。After step 105, the aforementioned 95% (v/v) methanol phase methanol may be selectively removed using the same concentration step as described above to obtain the crude extract or other conventional means to obtain the first extract. As for the above-mentioned concentration step or other conventional methods, as described above, it is no longer ambiguous here.

然後,如步驟107所示,利用體積比1:1之乙酸乙酯/水溶液,對前述第一萃取物進行第二分配萃取步驟,以劃分出乙酸乙酯相(約0.178公斤)以及第一水相。Then, as shown in step 107, the first extract is subjected to a second partition extraction step using an ethyl acetate/water solution having a volume ratio of 1:1 to fractionate the ethyl acetate phase (about 0.178 kg) and the first water. phase.

之後,如步驟109所示,利用正丁醇對上述第一水相 進行第三分配萃取步驟,以劃分出第四有機相與第二水相。Thereafter, as shown in step 109, the first aqueous phase is treated with n-butanol. A third partitioning extraction step is performed to divide the fourth organic phase from the second aqueous phase.

而後,如步驟111所示,對前述乙酸乙酯相進行第一矽膠管柱層析步驟,以獲得第一溶離液與殘留物。在上述例子中,第一矽膠管柱層析步驟可利用市售矽膠管柱,例如Kiesilgel 60(70~230網目(mesh)或230~400網目;Merk,Darmstadt,.Germany),並利用氯仿以及氯仿與甲醇之混合液(其中氯仿與甲醇的體積比為97:3)作為第一沖提液進行沖提。Then, as shown in step 111, the first ethyl acetate phase is subjected to a first xylene column chromatography step to obtain a first eluent and a residue. In the above example, the first cartridge column chromatography step may utilize a commercially available silicone column, such as Kiesilgel 60 (70-230 mesh or 230-400 mesh; Merk, Darmstadt, Germany), and utilizes chloroform and A mixture of chloroform and methanol (in which the volume ratio of chloroform to methanol was 97:3) was extracted as the first extract.

隨後,如步驟113所示,合併前述殘留物與第四有機相,再進行第二矽膠管柱層析步驟並分別利用體積比19:1、9:1或17:3之氯仿與甲醇進行沖提,其中以體積比17:3之氯仿與甲醇作為第二沖提液進行沖提,可獲得含有牡丹皮萃取物之第二溶離液。所得之第二溶離液可選擇性進行逆相層析管柱分離/HPLC步驟,可純化出如式(I)所示之牡丹皮苷D,具有如式(I)所示之結構: Subsequently, as shown in step 113, the residue and the fourth organic phase are combined, and the second rubber column chromatography step is carried out and washed with chloroform and methanol in a volume ratio of 19:1, 9:1 or 17:3, respectively. In the above, the leaching solution containing the peony bark extract is obtained by pulverizing with 17:3 by volume of chloroform and methanol as the second extract. The obtained second eluent can be selectively subjected to a reverse phase chromatography column separation/HPLC step, and the pepiside D as shown in the formula (I) can be purified, and has a structure represented by the formula (I):

上述所得之牡丹皮苷D經檢測後,其物化性質如下:分子量(MW)為510;溶點為122℃至127℃;UV(EtOH)λmax nm(log ε):258(4.20);IR(KBr)v max cm-1 :3393,1702,1603,1510;1 H-NMR(δ mult.(J in Hz),pyridine-d5 ):OCH3 (3.67, s),H-3(2.31(d,12.2)and 2.49(d,12.2)),H-5(3.09(d,6.8),),H-6(2.32(d,10.5)and 2.91(dd,10.5,6.8)),H-8(5.12(d,12.1)and 5.23(d,12.1)),H-9(5.94,s),H-10(1.67,s);13 C-NMR(δ,pyridine-d5 ):OCH3(55.2),C-1(88.7),C-2(85.8),C-3(44.6),C-4(105.8),C-5(43.7),C-6(23.3),C-7(71.6),C-8(60.9),C-9(101.6),C-10(19.6);FAB-MS m/z(rel.int.%):509([M-H+ ](20),151(100),137(15),121(13)。The physicochemical properties of the above obtained pepiside D were as follows: molecular weight (MW) was 510; melting point was 122 ° C to 127 ° C; UV (EtOH) λ max nm (log ε): 258 (4.20); IR (KBr) v max cm -1 : 3393,1702,1603,1510; 1 H-NMR (δ mult. ( J in Hz), pyridine-d 5 ): OCH 3 (3.67, s), H-3 (2.31 (d, 12.2) and 2.49 (d, 12.2)), H-5 (3.09 (d, 6.8),), H-6 (2.32 (d, 10.5) and 2.91 (dd, 10.5, 6.8)), H- 8 (5.12 (d, 12.1) and 5.23 (d, 12.1)), H-9 (5.94, s), H-10 (1.67, s); 13 C-NMR (δ, pyridine-d 5 ): OCH3 ( 55.2), C-1 (88.7), C-2 (85.8), C-3 (44.6), C-4 (105.8), C-5 (43.7), C-6 (23.3), C-7 (71.6) ), C-8 (60.9), C-9 (101.6), C-10 (19.6); FAB-MS m/z (rel.int.%): 509 ([MH + ](20), 151 (100 ), 137 (15), 121 (13).

上述之牡丹皮苷D溶解於二甲基亞碸(dimethyl sulfoxide;DMSO),配置成100 mg/mL之濃度,放置於室溫備用。The above-mentioned peony saponin D was dissolved in dimethyl sulfoxide (DMSO), and was placed at a concentration of 100 mg/mL, and left at room temperature for use.

實施例二:評估牡丹皮苷D之細胞毒性Example 2: Evaluation of cytotoxicity of peony saponin D

在此實施例中,首先係測試實施例一之牡丹皮苷D對於皮膚細胞、黑色素細胞或肝細胞,是否具有細胞毒性。適於測試用之皮膚細胞可例如為人類皮膚角質株化細胞(HaCaT;國立成功大學醫學院許漢銘醫師提供)以及人類皮膚纖維母細胞株(Hs68;BCRC編號:60038),測試用之黑色素細胞可例如為小鼠黑色素瘤細胞株(B16;ATCC編號:CRL-6322),測試用之肝細胞可例如為小家鼠正常肝細胞(BNL CL.2;ATCC TIB-73),其中ATCC為美國典型菌種中心(American Type Culture Collection;ATCC)之簡稱,BCRC為臺灣新竹食品工業研究與發展研究所(Food Industry Research and Development Institute;FIRDI)的生物資源保存與研究中心(Bioresource Collection and Research Center;BCRC)之簡稱。In this example, first, it was tested whether the peony saponin D of Example 1 is cytotoxic to skin cells, melanocytes or hepatocytes. Skin cells suitable for testing can be, for example, human skin keratinocytes (HaCaT; provided by Dr. Xu Hanming, National Chengchi University School of Medicine) and human skin fibroblast strain (Hs68; BCRC number: 60038), which can be used for testing melanocytes. For example, a mouse melanoma cell line (B16; ATCC number: CRL-6322), and the hepatocytes for testing may be, for example, a normal rat liver cell (BNL CL.2; ATCC TIB-73), wherein the ATCC is typical of the United States. Abbreviation for the American Type Culture Collection (ATCC), BCRC is the Bioresource Collection and Research Center (BCRC) of the Food Industry Research and Development Institute (FIRDI) in Taiwan. Abbreviation for).

上述細胞係利用無菌技術培養於細胞培養液中。HaCaT細胞株之細胞培養液為杜貝可改良之伊格氏培養液(Dulbecco’s Modified Eagle’s Medium,DMEM;Gibco,Grand Island,NY)並另添加10體積百分比之胎牛血清(fetal bovine serum;FBS;Hazelton Product,Denver,PA,U.S.A.)以及1 mM之丙酮酸鈉。B16細胞株、BNL CL.2細胞株以及Hs68細胞株之細胞培養液為DMEM(Gibco,Grand Island,NY)並另添加10%(v/v)之FBS(fetal bovine serum;Hazelton Product,Denver,PA,U.S.A.)。The above cell lines are cultured in a cell culture medium using aseptic techniques. The cell culture medium of the HaCaT cell strain is Dulbecco's Modified Eagle's Medium (DMEM; Gibco, Grand Island, NY) and an additional 10 volume percent of fetal bovine serum (FBS; Hazelton Product, Denver, PA, USA) and 1 mM sodium pyruvate. The cell culture medium of B16 cell line, BNL CL.2 cell line and Hs68 cell line was DMEM (Gibco, Grand Island, NY) and 10% (v/v) FBS (fetal bovine serum; Hazelton Product, Denver, PA, USA).

上述HaCaT細胞株、B16細胞株、BNL CL.2細胞株以及Hs68細胞株之細胞置於5%的CO2 、95%的空氣以及37℃下之細胞培養箱中培養,依細胞狀況而定,大約每2至3天更換培養液。當細胞於培養皿之滿度(confluence)達約80%至約100%時,將培養液移除並以一倍(1×)的磷酸鹽緩衝溶液(phosphate buffered saline;PBS)清洗後,利用胰蛋白酶(trypsin,1×)使細胞形成單細胞懸浮液,然後進行繼代培養或進行實驗。The cells of the HaCaT cell line, the B16 cell line, the BNL CL.2 cell line, and the Hs68 cell line were cultured in a 5% CO 2 , 95% air, and a cell culture incubator at 37 ° C depending on the cell condition. The culture medium was changed approximately every 2 to 3 days. When the cell has a confluence of about 80% to about 100% in the culture dish, the culture solution is removed and washed with double (1×) phosphate buffered saline (PBS), and then utilized. Trypsin (1×) allowed the cells to form a single cell suspension, which was then subcultured or tested.

此時實施例係利用MTT法評估細胞存活率。申言之,上述HaCaT細胞株、B16細胞株、BNL CL.2細胞株以及Hs68細胞株之細胞,以1.0×105 /mL之細胞密度種植於96孔盤之每孔中,然後在37℃保持溼度之5%二氧化碳濃度下培養至少24小時。之後,將不同濃度(0至100μM)之實施例一的牡丹皮苷D或維生素C(ascorbic acid,AA;抗壞血酸;Sigma Chemical Co,St.Louis,U.S.A.),分別添加於上述細胞中,其中維生素C係作為正對照組。培養72小時 後,每孔細胞加入10 μL之溴化3-(4,5-二甲基唑-2)-2,5-二苯基四氮唑[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide;MTT四氮唑;5 mg/mL],於37℃作用4小時後,移除上清液,再加入100 μL之二甲亞碸(dimethyl sulfoxide;DMSO;Sigma Chemical Co,St.Louis,U.S.A.)溶解MTT甲臢(MTT formazan;MTT四氮唑被還原後之產物),震盪10分鐘後,測量其於波長570 nm的吸光值以計算細胞存活率(cell viability),其結果如第2圖所示。上述吸光值之測量可根據例如CellTiter 96 AQ之使用手冊(CellTiter 96 AQ,Promega,Madison.WI,U.S.A.),利用例如多功能微量盤測讀機(Multi-Detection Microplate Reader;SynergyTM 2,BioTek Instruments,Inc.,U.S.A.)進行。At this time, the examples were evaluated for cell viability using the MTT method. In other words, the cells of the HaCaT cell line, the B16 cell line, the BNL CL.2 cell line, and the Hs68 cell line were planted in each well of a 96-well plate at a cell density of 1.0×10 5 /mL, and then at 37 ° C. Incubate for at least 24 hours while maintaining a humidity of 5% carbon dioxide. Thereafter, different concentrations (0 to 100 μM) of the peony saponin D or vitamin C (ascorbic acid, AA; ascorbic acid; Sigma Chemical Co, St. Louis, USA) of Example 1 were separately added to the above cells, wherein the vitamins The C line was used as a positive control group. After 72 hours of culture, 10 μL of 3-(4,5-dimethylazole-2)-2,5-diphenyltetrazolium bromide [3-(4,5-dimethylthiazol-2) was added to each well of cells. -yl)-2,5-diphenyltetrazolium bromide; MTT tetrazolium; 5 mg/mL], after 4 hours at 37 ° C, the supernatant was removed, and 100 μL of dimethyl sulfoxide (DMSO) was added. ;Sigma Chemical Co, St. Louis, USA) Dissolved MTT formazan (MTT formazan; product of MTT tetrazolium after reduction), after 10 minutes of shaking, measured its absorbance at a wavelength of 570 nm to calculate cell viability ( Cell viability), the result is shown in Fig. 2. The above-mentioned absorbance measurement can be performed according to, for example, the CellTiter 96 AQ manual (CellTiter 96 AQ, Promega, Madison. WI, USA), using, for example, a Multi-Detection Microplate Reader; Synergy TM 2, BioTek Instruments , Inc., USA).

請參閱第2A圖至第2F圖,其係顯示根據本發明數個實施例之HaCaT細胞株、B16細胞株、BNL CL.2細胞株以及Hs68細胞株與實施例一之牡丹皮苷D或維生素C作用72小時後的細胞存活率曲線圖。第2A圖至第2F圖係以未經處理之對照組的細胞存活率(%)作為100%,其他處理組之細胞存活率與未處理的對照組相比,經換算後所得之值,其中圖號●係代表HaCaT細胞株之細胞存活率曲線,圖號▲係代表B16細胞株之細胞存活率曲線,圖號◆係代表BNL CL.2細胞株之細胞存活率曲線,圖號■係代表Hs68細胞株之細胞存活率曲線,圖號☆係代表添加實施例一的牡丹皮苷D之細胞存活率曲線,而圖號▽係代表添加維生素C之細胞存活率曲線。每筆數值至少由大於或等 於3個樣本數所得出。Please refer to FIGS. 2A to 2F, which show HaCaT cell strain, B16 cell strain, BNL CL.2 cell strain and Hs68 cell strain according to several embodiments of the present invention, and the peony saponin D or vitamin of Example 1. A graph of cell viability after 72 hours of C action. Fig. 2A to Fig. 2F show the cell survival rate (%) of the untreated control group as 100%, and the cell survival rate of the other treatment groups was converted to a value obtained by comparison with the untreated control group, wherein Figure No. ● represents the cell viability curve of HaCaT cell line, the figure number ▲ represents the cell viability curve of B16 cell line, and the figure number ◆ represents the cell viability curve of BNL CL.2 cell line, and the figure number is representative. The cell survival rate curve of the Hs68 cell line, the figure number ☆ represents the cell viability curve of the addition of the peony saponin D of Example 1, and the figure number ▽ represents the cell survival rate curve of the addition of vitamin C. Each value is at least greater than or equal It was obtained from 3 sample numbers.

由第2A圖至第2F圖之結果可知,在HaCaT細胞株、B16細胞株、BNL CL.2細胞株以及Hs68細胞株中添加高濃度(100 μM)之牡丹皮萃取物,影響細胞生長的程度較少,其細胞存活率仍維持約大於70%,因此實施例一之牡丹皮萃取物在添加濃度高達100 μM時,對上述細胞株並無細胞毒性。其次,由第2E圖之結果可知,在HaCaT細胞株中添加實施例一之牡丹皮萃取物的濃度越高,越可提升HaCaT細胞存活率。相較之下,由第2D圖之結果可知,添加高濃度(100 μM)之維生素C於BNL CL.2細胞株之細胞存活率僅約50%,推測維生素C的添加濃度較高,影響細胞株培養液之pH值,進而抑制細胞之生長。From the results of Fig. 2A to Fig. 2F, it was found that a high concentration (100 μM) of peony bark extract was added to HaCaT cell line, B16 cell line, BNL CL.2 cell line and Hs68 cell line to affect the degree of cell growth. Less, the cell survival rate is still maintained above about 70%, so the peony bark extract of Example 1 is not cytotoxic to the above cell lines at the added concentration of up to 100 μM. Next, as is apparent from the results of Fig. 2E, the higher the concentration of the peony bark extract of Example 1 added to the HaCaT cell line, the higher the HaCaT cell survival rate. In contrast, as can be seen from the results of the 2D graph, the cell viability of the high concentration (100 μM) of vitamin C in the BNL CL.2 cell line is only about 50%, and it is speculated that the vitamin C is added at a higher concentration, affecting the cells. The pH of the culture medium of the strain further inhibits the growth of the cells.

實施例三:評估牡丹皮苷D體外抑制蘑菇酪胺酸酶活性之功效Example 3: Assessing the efficacy of pecitin D in inhibiting mushroom tyrosinase activity in vitro

酪胺酸(tyrosine)經酪胺酸酶(tyrosinase)催化形成多巴二羥苯丙氨酸(dihydroxyphenylalanine;DOPA),當DOPA再度經酪胺酸酶催化則形成多巴醌(DOPAquinone),一連串之催化反應引起黑色素合成(melanogenesis),藉由磨菇中取得之酪胺酸酶,進行細胞外初步篩選之酪胺酸酶活性抑制測試。Tyrosine is catalyzed by tyrosinase to form dominophenylalanine (DOPA). When DOPA is catalyzed by tyrosinase, it forms a series of DOPAquinone. The catalytic reaction causes melanogenesis, and the tyrosinase activity inhibition test of the extracellular preliminary screening is performed by the tyrosinase obtained in the mushroom.

在此測試中,實施例一之牡丹皮苷D係配製成0、5μM、25μM、50μM及100 μM等濃度。對照組則取維生素C之粉末,新鮮配製成0、5μM、25μM、50μM及100 μM等濃度後,避光儲存。接著,各取2 μL之牡丹皮苷D(試 驗組)或維生素C(正對照組)混合於18 μL之DMSO,加入96孔盤中,並加或不加入25 μL之100 Units的蘑菇酪胺酸酶溶液,於室溫下反應10分鐘,以475 nm波長下測定蘑菇酪胺酸酶之背景值。隨後,避光加入155 μL之2.5 mM L-DOPA溶液於室溫下混合。然後,利用分光光度計,例如SynergyTM 2多功能微量盤測讀機(Multi-Mode Microplate Reader;BioTek,U.S.A.),測量各孔的蘑菇酪胺酸酶之吸光值,再依下式(II)計算其酪胺酸酶活性抑制率,計算不同濃度的化合物對於蘑菇酪胺酸酶之抑制活性,其結果如第3圖之所示: In this test, the peony saponin D of Example 1 was formulated to a concentration of 0, 5 μM, 25 μM, 50 μM, and 100 μM. In the control group, vitamin C powder was taken and freshly prepared to a concentration of 0, 5 μM, 25 μM, 50 μM, and 100 μM, and stored in the dark. Next, take 2 μL of Mucortin D (test group) or Vitamin C (positive control group) in 18 μL of DMSO, add to 96-well plate, or add 25 μL of 100 Units of mushroom tyramine. The acidase solution was reacted at room temperature for 10 minutes to determine the background value of the mushroom tyrosinase at a wavelength of 475 nm. Subsequently, 155 μL of a 2.5 mM L-DOPA solution was added in the dark to mix at room temperature. Then, using a spectrophotometer, e.g. Synergy TM 2 multifunction machine microplate readings (Multi-Mode Microplate Reader; BioTek , USA), measuring the absorbance of each well of mushroom tyrosinase, and then by the formula (II) The inhibition rate of tyrosinase activity was calculated, and the inhibitory activities of the compounds at different concentrations on the mushroom tyrosinase were calculated. The results are shown in Fig. 3:

在式(II)中,Ab代表含溶劑、酪胺酸、PBS、酪胺酸酶,但不含牡丹皮苷D或維生素C;At代表含牡丹皮苷D及酪胺酸、PBS、酪胺酸酶;而A0代表含牡丹皮苷D或維生素C、酪胺酸、PBS,但不含酪胺酸酶。In formula (II), Ab stands for solvent, tyrosine, PBS, tyrosinase, but does not contain pepiside D or vitamin C; At represents peony glucoside D and tyrosine, PBS, tyramine Acidase; and A0 represents peony saponin D or vitamin C, tyrosine, PBS, but does not contain tyrosinase.

請參閱第3圖,其係繪示利用實施例一之牡丹皮苷D抑制蘑菇酪胺酸酶活性的直方圖,其橫軸為酪胺酸酶或維生素C,縱軸為蘑菇酪胺酸酶之抑制活性率(%)。由第3圖之結果可知,實施例一之牡丹皮苷D可抑制酪胺酸酶活性,達約60%至70%之酪胺酸酶的抑制率。相較於同濃度的維生素C對酪胺酸酶活性的抑制程度,實施例一之牡丹皮苷D對酪胺酸酶活性的抑制程度,約維生素C的八成左 右。Please refer to Fig. 3, which is a histogram showing inhibition of mushroom tyrosinase activity by the use of the peony glucoside D of the first embodiment, wherein the horizontal axis is tyrosinase or vitamin C, and the vertical axis is mushroom tyrosinase. The inhibition activity rate (%). As is apparent from the results of Fig. 3, the pebbardin D of Example 1 inhibited tyrosinase activity and reached an inhibition rate of about 60% to 70% of tyrosinase. Compared with the degree of inhibition of tyrosinase activity by the same concentration of vitamin C, the degree of inhibition of tyrosinase activity by peony saponin D of Example 1 is about 80% of that of vitamin C. right.

2.細胞外黑色素含量之分析2. Analysis of extracellular melanin content

此項評估係測定細胞外黑色素之含量。簡言之,B16細胞於96孔盤中每孔種1.0×105 細胞,然後在37℃保持溼度之5%二氧化碳濃度下培養至少24小時。之後,將5μM至100μM之牡丹皮苷D或維生素C(AA)混合於含有100 nm α-MSH之不含酚紅(phenol red)的細胞培養液DMEM中。B16細胞經上述處理並於37℃反應72小時後,每孔取100 μL細胞培養液加入96孔盤中,利用分光光度計,例如上述之多功能微量盤測讀機,測量各孔細胞培養液於405 nm下的吸光值,並與對照組(DMSO最終濃度為0.1%)以及正對照組(維生素C)比較。而後,計算牡丹皮苷D或維生素C本身之吸光值,並換算成牡丹皮苷D或維生素C作用於細胞後抑制黑色素生成量能力。This assessment measures the amount of extracellular melanin. Briefly, B16 cells per well in 96-well plates Species 1.0 × 10 5 cells, and then maintained under a carbon dioxide concentration of 5% humidity of at least 24 hours culture at 37 ℃. Thereafter, 5 μM to 100 μM of puerarin D or vitamin C (AA) was mixed in a cell culture medium DMEM containing 100 nm of α-MSH and containing no phenol red. After the B16 cells were treated for 72 hours at 37 ° C, 100 μL of the cell culture solution per well was added to a 96-well plate, and the cell culture solution of each well was measured by a spectrophotometer, such as the above-mentioned multifunctional microplate reader. The absorbance at 405 nm was compared with the control group (final concentration of DMSO 0.1%) and the positive control group (vitamin C). Then, the absorbance of the peony saponin D or the vitamin C itself is calculated, and converted into the ability of melanin D or vitamin C to inhibit melanin production after acting on the cells.

請參閱第4A圖,其係繪示評估實施例一之牡丹皮苷D對於抑制細胞外黑色素含量之相對比率的直方圖,其中橫軸依序為牡丹皮苷D以及維他命C,縱軸為抑制細胞外黑色素含量之相對比率(%)。填滿右上斜線之長條表示利用濃度5μM之牡丹皮苷D與維他命C進行處理。填滿左上斜線之長條表示利用濃度25μM之牡丹皮苷D與維他命C進行處理。填滿交叉線之長條則表示利用濃度50μM之牡丹皮苷D與維他命C進行處理。填滿黑色之長條則表示利用濃度100μM之牡丹皮苷D與維他命C進行處理。Please refer to FIG. 4A, which is a histogram for evaluating the relative ratio of pepiside D to inhibiting extracellular melanin content in Example 1, wherein the horizontal axis is saponin D and vitamin C, and the vertical axis is inhibition. The relative ratio (%) of extracellular melanin content. The long strips filled with the upper right oblique line indicate treatment with lycopene D at a concentration of 5 μM and vitamin C. The long strips filled with the upper left oblique line indicate treatment with peony saponin D at a concentration of 25 μM and vitamin C. Filling the strips of the cross-line means treating with 50 μM of puerarin D and vitamin C. Filling the black strips means treating with 100 μM of puerarin D and vitamin C.

由第4A圖之結果可以得知,相較於對照組,牡丹皮苷D可有效減少B16細胞外黑色素的形成,且與維他命C 的效果相當。因此,上述結果證實,實施例一之牡丹皮苷D可有效減少細胞外黑色素的形成。From the results of Figure 4A, it can be seen that compared with the control group, pepiside D can effectively reduce the formation of melanin outside B16 cells, and with vitamin C. The effect is quite. Therefore, the above results confirmed that the peony saponin D of Example 1 can effectively reduce the formation of extracellular melanin.

3.細胞內黑色素含量之分析3. Analysis of intracellular melanin content

此項評估係接續前述細胞外黑色素含量測定,進一步評估細胞內黑色素含量測定。將上述細胞以PBS清洗後抽乾後,加入100 μL之1N NaOH溶解細胞後,利用分光光度計,例如上述之多功能微量盤測讀機,於405 nm波長測量各孔細胞溶解液於405 nm下的吸光值,並與對照組(DMSO最終濃度為0.1%)以及正對照組(維生素C)比較。而後,計算牡丹皮苷D或維生素C本身之吸光值,並換算成牡丹皮苷D或維生素C作用於細胞內黑色素含量。This evaluation is based on the determination of the extracellular melanin content described above to further evaluate the intracellular melanin content determination. After the cells were washed with PBS and then drained, the cells were lysed by adding 100 μL of 1N NaOH, and then the cell lysate was measured at 405 nm using a spectrophotometer, such as the above-mentioned multifunctional microplate reader. The absorbance value was compared with the control group (final concentration of DMSO 0.1%) and the positive control group (vitamin C). Then, the absorbance of the peony saponin D or the vitamin C itself is calculated and converted into melanin content of the peony saponin D or vitamin C.

請參閱第4B圖,其係繪示評估實施例一之牡丹皮苷D對於抑制細胞內黑色素含量之相對比率的直方圖,其中橫軸依序為牡丹皮苷D以及維他命C,縱軸為抑制細胞內黑色素含量之相對比率(%)。填滿右上斜線之長條表示利用濃度5μM之牡丹皮苷D與維他命C進行處理。填滿左上斜線之長條表示利用濃度25μM之牡丹皮苷D與維他命C進行處理。填滿交叉線之長條則表示利用濃度50μM之牡丹皮苷D與維他命C進行處理。填滿黑色之長條則表示利用濃度100μM之牡丹皮苷D與維他命C進行處理。Please refer to FIG. 4B, which is a histogram for evaluating the relative ratio of the peony saponin D to inhibiting the melanin content in the cells, wherein the horizontal axis is melanin D and vitamin C, and the vertical axis is inhibition. The relative ratio (%) of melanin content in cells. The long strips filled with the upper right oblique line indicate treatment with lycopene D at a concentration of 5 μM and vitamin C. The long strips filled with the upper left oblique line indicate treatment with peony saponin D at a concentration of 25 μM and vitamin C. Filling the strips of the cross-line means treating with 50 μM of puerarin D and vitamin C. Filling the black strips means treating with 100 μM of puerarin D and vitamin C.

由第4B圖之結果可以得知,相較於對照組,牡丹皮苷D可有效減少B16細胞內黑色素的形成,且與維他命C的效果相當。因此,上述結果證實,實施例一之牡丹皮苷D可有效減少細胞內黑色素的形成。As can be seen from the results of Fig. 4B, pepiside D was effective in reducing the formation of melanin in B16 cells compared with the control group, and was equivalent to the effect of vitamin C. Therefore, the above results confirmed that the peony saponin D of Example 1 can effectively reduce the formation of melanin in cells.

4.評估黑色素生成時之相關基因及蛋白質的表現4. Assess the performance of related genes and proteins during melanin production (1)北方墨點法(Western blotting analysis)(I)(1) Western blotting analysis (I) (1.1)萃取RNA(1.1) Extracting RNA

將B16細胞以1×105 /ml之密度接種於6 well plate中,培養24小時,將100 μM之牡丹皮苷D與維他命C各別混合於含有100 nM α-MSH之新鮮培養液,反應0、24、48、72小時後,萃取總RNA並進行定量分析。B16 cells were seeded in a 6 well plate at a density of 1 × 10 5 /ml, cultured for 24 hours, and 100 μM of pecitin D and vitamin C were separately mixed in a fresh medium containing 100 nM α-MSH. After 0, 24, 48, and 72 hours, total RNA was extracted and quantitatively analyzed.

上述所得之RNA濃度可運用習知方法,利用分光光度計於OD260 nm 以及OD280 nm 測量吸光值而得知。本發明所述之技術領域中具有通常知識者應可熟知,在此不另贅述。The RNA concentration obtained above can be known by a conventional method using a spectrophotometer to measure the absorbance at OD 260 nm and OD 280 nm . Those of ordinary skill in the art to which the present invention pertains should be well known and will not be further described herein.

所得之總RNA經定量後,利用同步反轉錄聚合酶鏈鎖反應(real-time reverse-transcription polymerase chain reaction;real-time RT-PCR),檢測實施例一之牡丹皮萃取物是否調控NER系統之相關基因表現。After the total RNA obtained is quantified, the real-time reverse-transcription polymerase chain reaction (real-time RT-PCR) is used to detect whether the peony peel extract of the first embodiment regulates the NER system. Related gene expression.

上述real-time RT-PCR可參考習知方法或下述方式進行。首先,配製反轉錄反應液,其係利用0.1% DEPC-H2 O將所得之總RNA之濃度調整為2 mg/mL後,將體積補至12.5 μL,並加入1 μL之寡聚胸苷酸〔oligo(dT)〕引子混合均勻,於70℃反應2分鐘。然後,將前述反應混合物迅速置於冰上,再加入4 μL之5倍(5×)莫洛尼氏鼠白血病病毒(moloney murine leukemia virus;MMLV)之反轉錄反應緩衝溶液(MMLV-RT buffer solution)、1 μL之10 mM dNTPs、0.5 μL之核醣核酸酶抑制劑(RNase inhibitor)以及1 μL之MMLV反轉錄酶(MMLV RTase),於42℃反應1小時並於94℃反應5分鐘,以合成cDNA。之後,加入冰的二次去離子水(ddH2 O)將cDNA的體積補足至100 μL,即製備完成 cDNA並存放於-80℃。The above real-time RT-PCR can be carried out by referring to a conventional method or the following manner. First, a reverse transcription reaction solution was prepared which adjusted the concentration of the total RNA obtained to 2 mg/mL with 0.1% DEPC-H 2 O, and the volume was made up to 12.5 μL, and 1 μL of oligo-thymidylate was added. [oligo (dT)] The primer was uniformly mixed and reacted at 70 ° C for 2 minutes. Then, the above reaction mixture was quickly placed on ice, and then 4 μL of 5 times (5×) Moloney murine leukemia virus (MMLV) reverse transcription reaction buffer solution (MMLV-RT buffer solution) was added. 1 μL of 10 mM dNTPs, 0.5 μL of RNase inhibitor and 1 μL of MMLV reverse transcriptase (MMLV RTase), reacted at 42 ° C for 1 hour and reacted at 94 ° C for 5 minutes to synthesize cDNA. Thereafter, the volume of cDNA was made up to 100 μL by adding iced deionized water (ddH 2 O), and the cDNA was prepared and stored at -80 °C.

接下來,取上述10 μL之cDNA(約10 ng至50 ng),與12.5 μL之SYBR Green混合物、2.5 μl 10 μM之各基因引子對混合物(包括上游引子與上游引子)以及ddH2 O,混合為總體積25μL之反應溶液。前述各基因適用的上游引子與上游引子之具體例如第1表之所示: Next, take the above 10 μL of cDNA (about 10 ng to 50 ng), mix with 12.5 μL of SYBR Green mixture, 2.5 μl of 10 μM gene primer pair (including upstream primer and upstream primer) and ddH 2 O. A total volume of 25 μL of the reaction solution. Specific examples of the upstream primer and the upstream primer for each of the aforementioned genes are shown in Table 1, for example:

上述反應溶液經低轉速離心後,進行同步定量PCR(real-time quantitative PCR),其反應條件如下:於94℃進行50秒至60秒使雙股模板DNA分離(ds DNA denaturation),於55℃至60℃進行50秒至60秒使引子黏合(annealing),於72℃進行50秒至2分鐘使DNA延長反應(extension),以此為一個循環,共重複進行40個循環的反應,然後於72℃進行5分鐘至7分鐘。待循環完畢,將PCR產物進行瓊脂電泳分析,並利用市售軟體,例如amplification plot或其他功能替代的軟體,分析上述所得NER系統之相關基因的螢光強度,其結果如第5A圖之所 示。After the above reaction solution was centrifuged at a low rotation speed, real-time quantitative PCR was carried out under the following conditions: separation of the double-stranded template DNA (dDNA denaturation) at 55 ° C for 50 seconds to 60 seconds at 55 ° C The primer is bonded to 60 ° C for 50 seconds to 60 seconds, and the DNA is extended at 72 ° C for 50 seconds to 2 minutes, thereby repeating the reaction for 40 cycles, and then repeating the reaction for 40 cycles. It is carried out at 72 ° C for 5 minutes to 7 minutes. After the cycle is completed, the PCR product is subjected to agar electrophoresis analysis, and the fluorescence intensity of the related gene of the obtained NER system is analyzed by using a commercially available software such as an amplification plot or other functional replacement software, and the result is as shown in FIG. 5A. Show.

請參閱第5A圖,其係顯示利用實施例一之牡丹皮苷D對於B16細胞株於黑色素生成時之相關基因表現的瓊脂膠體照片,其中每條色帶上方的數值代表黑色素生成時之相關基因相對於β-肌動蛋白之基因表現量(density ratio;由螢光強度換算而得)。Please refer to FIG. 5A, which is a photograph showing the agar colloid of the related gene expression of the B16 cell line in the melanin production using the peony saponin D of Example 1. The value above each band represents the gene related to melanin production. The gene expression amount (density ratio; obtained from fluorescence intensity) relative to β-actin.

由第5A圖之結果顯示,相較於控制組,B16細胞株在與牡丹皮苷D反應24小時後,可明顯抑制黑色素生成時之相關基因(例如MC1R、MITF、酪胺酸酶、TRP-1、TRP-2等)的表現量,顯示實施例一之牡丹皮萃取物確實可抑制黑色素生成時之相關基因表現量,有助於達到抑制黑色素生成之目的。From the results of Figure 5A, the B16 cell line significantly inhibited the genes involved in melanin production after 24 hours of reaction with pepiside D (eg MC1R, MITF, tyrosinase, TRP- compared to the control group). 1. The amount of TRP-2, etc., shows that the peony bark extract of Example 1 can inhibit the expression of related genes when melanin is produced, and contributes to the inhibition of melanin production.

(2)西方墨點法(Western blotting analysis)(I)(2) Western blotting analysis (I) (2.1)萃取蛋白質(2.1) Extracting proteins

將上述10 cm2 培養皿的實驗組B16細胞與100 nM α-MSH以及不同濃度之牡丹皮苷D或維他命C反應72小時達反應時間後,分別收集上清液至15 mL離心管,再利用胰蛋白酶(trypsin,1×)取下細胞,經離心移除上清液後,進行蛋白質萃取,以西方墨點法分析相關蛋白表現。The experimental group B16 cells of the above 10 cm 2 culture dish were reacted with 100 nM α-MSH and different concentrations of pepiside D or vitamin C for 72 hours, and then the supernatant was separately collected into a 15 mL centrifuge tube and reused. Trypsin (1×) was used to remove the cells, and the supernatant was removed by centrifugation, followed by protein extraction, and the protein expression was analyzed by Western blotting.

上述所得之蛋白質濃度可運用習知方法,利用不同濃度的BSA建立標準曲線,再將上述萃取而得之蛋白質的吸光值帶入線性回歸公式,以換算得知。本發明所述之技術領域中具有通常知識者應可熟知建立標準曲線並換算蛋白質濃度,在此不另贅述。The protein concentration obtained above can be determined by a conventional method using different concentrations of BSA, and the absorbance of the extracted protein is brought into a linear regression formula to be converted. Those of ordinary skill in the art to which the present invention pertains should be familiar with establishing standard curves and converting protein concentrations, which are not described herein.

(2.2)蛋白質電泳分析(2.2) Protein electrophoresis analysis

接下來,上述各組的蛋白質可利用十二烷基硫酸鈉-聚丙烯醯胺膠體電泳分析(SDS-PAGE electrophoresis assay)進行評估。首先,根據第2表製備10%之下層膠(Running gel)並注入製膠器中,膠體上層加入蒸餾水以壓平膠體液面,待凝固後移除上層之ddH2 O並吸乾殘存水份。Next, the proteins of the above groups can be evaluated using a sodium dodecyl sulfate-polyacrylamide colloidal electrophoresis assay (SDS-PAGE electrophoresis assay). First, 10% of the running gel was prepared according to the second table and injected into the gluer. Distilled water was added to the upper layer of the colloid to flatten the colloidal liquid surface. After solidification, the upper layer of ddH 2 O was removed and the remaining moisture was absorbed. .

然後,根據第3表製備7.5%上層膠(stacking gel),注入下層膠上方後,再插入齒模,待凝固後移除齒模即完成。Then, 7.5% of a stacking gel was prepared according to the third table, and after being injected into the lower layer of the underlayer, the tooth mold was inserted, and the tooth mold was removed after solidification.

隨後,取上述各組的蛋白質經換算後,與5×Loading dye buffer以5:1之體積比混合,於100℃處理5分鐘後,移至4℃冷卻備用。Subsequently, the proteins of the above groups were converted, mixed with 5× Loading dye buffer in a volume ratio of 5:1, treated at 100 ° C for 5 minutes, and then moved to 4 ° C for cooling.

將上述製備好的膠片放入市售電泳槽(例如商品名miniVE,Complete,GE-80-6418-77,GE Healthcare,U.S.A.)中,以90伏特之電壓預跑15分鐘至20分鐘。然後,依序加入標準蛋白分子量標記(standard protein MW marker)以 及上述各組的蛋白質後,以130伏特之電壓進行電泳分析。The film prepared above was placed in a commercially available electrophoresis tank (for example, trade name miniVE, Complete, GE-80-6418-77, GE Healthcare, U.S.A.), and pre-run for 15 minutes to 20 minutes at a voltage of 90 volts. Then, the standard protein MW marker is sequentially added to After the proteins of the above groups, the electrophoresis was carried out at a voltage of 130 volts.

然後,將上述SDS-PAGE之電泳膠體取下,進行西方轉漬法分析(Western blotting assay)。首先,將市售轉印膜,例如聚偏二氟乙烯轉印膜(polyvinylidene difluoride membrans,PVDF membrane;例如商品名PolyScreen PVDF Hybridization Transfer Membrane,PK-NEF1002,PerkinElmer,USA)浸泡於甲醇5分鐘,以改變PVDF membrane之極性。接下來,於組合卡匣(Gel holder cassette)中依序放上海綿墊、濾紙以及電泳膠體,再覆蓋PVDF轉印膜,清除其中之氣泡後,再依序放上濾紙、海綿墊並將卡匣蓋上夾緊,置入市售西方轉漬槽(例如商品名Mighty small transphor,TE 22,Amersham biosciences,U.S.A.)中,以60伏特之電壓、200毫安培、於4℃下進行轉漬90分鐘,將蛋白質轉印至PVDF轉印膜上。之後,將經轉漬完成帶有蛋白質之PVDF轉印膜利用0.1% PBST(Tween-20/PBS)清洗後,即進行特定蛋白質表現之免疫染色。Then, the above-mentioned SDS-PAGE electrophoresis colloid was taken out and subjected to Western blotting assay. First, a commercially available transfer film, such as polyvinylidene difluoride membrans (PVDF membrane; for example, trade name PolyScreen PVDF Hybridization Transfer Membrane, PK-NEF1002, PerkinElmer, USA), is immersed in methanol for 5 minutes to Change the polarity of the PVDF membrane. Next, put the sponge pad, filter paper and electrophoresis gel in the Gel holder cassette, cover the PVDF transfer film, remove the bubbles, and then put the filter paper, sponge pad and card in sequence. The crucible is clamped and placed in a commercially available western transfer tank (for example, trade name Mighty small transphor, TE 22, Amersham biosciences, USA), and subjected to 60 volts at a voltage of 200 volts at 4 ° C. Minutes, the protein was transferred to a PVDF transfer film. Thereafter, the PVDF transfer film with protein was completely washed with 0.1% PBST (Tween-20/PBS), and immunostaining of specific protein expression was performed.

上述轉漬完成之PVDF轉印膜浸泡於含有5%脫脂奶粉之0.1% PBST(Tween-20/PBS)中,輕微搖晃作用60分鐘,以進行非特異性抗原阻斷(non-specific antigen blocking)。接著,以0.1% PBST清洗PVDF轉印膜後,利用0.1% PBST配製一級抗體(1:1000),將PVDF轉印膜完全浸泡於一級抗體於4℃下反應至隔夜。然後,再以0.1% PBST清洗PVDF轉印膜,並加入FITC二級抗體(1:1000)於4℃下作用2-3小時。之後,於4℃以0.1% PBST清洗PVDF轉印 膜2小時,加入呈色劑與PVDF轉印膜反應3分鐘。而後,再加入顯色劑混合反應,隨即利用冷光影像分析儀(Avegene Life Science,LIAS ChemLite Series,ChemLite 200FA/400FA)儲存影像。前述之冷光影像分析儀可根據儲存的影像,偵測Luminol(Cyclic phthalhydrazides)由基態被激發成激發態、再回復到基態時釋出冷光的強度,並進行定量分析。The above-mentioned PVDF transfer film was immersed in 0.1% PBST (Tween-20/PBS) containing 5% skim milk powder and shaken gently for 60 minutes for non-specific antigen blocking. . Next, after washing the PVDF transfer film with 0.1% PBST, the primary antibody (1:1000) was prepared using 0.1% PBST, and the PVDF transfer film was completely immersed in the primary antibody and reacted at 4 ° C until overnight. Then, the PVDF transfer film was washed with 0.1% PBST, and added with FITC secondary antibody (1:1000) at 4 ° C for 2-3 hours. After that, the PVDF transfer was washed with 0.1% PBST at 4 °C. The film was reacted for 2 hours, and a coloring agent was added to react with the PVDF transfer film for 3 minutes. Then, a color developer mixing reaction was added, and images were stored using a cold light image analyzer (Avegene Life Science, LIAS ChemLite Series, ChemLite 200FA/400FA). The luminescence image analyzer described above can detect the intensity of Luminol (Cyclic phthalhydrazides) released from the ground state when excited to an excited state and then return to the ground state according to the stored image, and quantitatively analyze.

上述適用的一級抗體之具體例可如第4表所示: Specific examples of the above applicable primary antibodies can be as shown in Table 4:

請參閱第5B圖,其係顯示利用實施例一之牡丹皮苷D對於B16細胞株於黑色素生成時之相關蛋白表現的西方墨點分析圖,其中每條色帶上方的數值代表黑色素生成時之相關基因相對於β-肌動蛋白之蛋白質表現量(density ratio;由螢光強度換算而得)。Please refer to FIG. 5B, which is a Western blot analysis diagram showing the expression of related proteins of the B16 cell line in the melanin production using the peony saponin D of Example 1. The value above each band represents the time when melanin is produced. The protein expression of the related gene relative to β-actin (density ratio; obtained from fluorescence intensity).

由第5B圖可知,相較於控制組,B16細胞株在與牡丹皮苷D反應24小時後,可明顯抑制黑色素生成時之相關 蛋白(例如MC1R、MITF、酪胺酸酶、TRP-1、TRP-2等)的表現量,顯示實施例一之牡丹皮萃取物確實可抑制黑色素生成時之相關蛋白表現量,有助於達到抑制黑色素生成之目的。As can be seen from Fig. 5B, compared with the control group, the B16 cell line can significantly inhibit the formation of melanin after reacting with pepiside D for 24 hours. The amount of protein (for example, MC1R, MITF, tyrosinase, TRP-1, TRP-2, etc.) shows that the peony bark extract of Example 1 can inhibit the expression of related proteins in melanin production, which is helpful to achieve Inhibits melanin production.

上述結果顯示實施例一之牡丹皮苷D可抑制黑色素生成時之相關基因之mRNA與蛋白質合成,進而抑制黑色素生成。The above results show that the peony saponin D of Example 1 can inhibit the synthesis of mRNA and protein of related genes when melanin is produced, thereby inhibiting melanin production.

(3)評估黑色素生成時之相關蛋白質表現(II)(3) Evaluation of related protein expression during melanin production (II)

將上述10 cm2 培養皿的實驗組B16細胞與100 nM α-MSH以及不同濃度之牡丹皮苷D或維他命C反應72小時達反應時間後,分別收集上清液至15 mL離心管,再利用胰蛋白酶(trypsin,1×)取下細胞,經離心移除上清液後,加入500 μL之4%三聚甲醛(paraformaldehyde)於4℃反應1小時固定細胞並分析相關蛋白質表現。The experimental group B16 cells of the above 10 cm 2 culture dish were reacted with 100 nM α-MSH and different concentrations of pepiside D or vitamin C for 72 hours, and then the supernatant was separately collected into a 15 mL centrifuge tube and reused. Trypsin (1×) was used to remove the cells. After removing the supernatant by centrifugation, 500 μL of 4% paraformaldehyde was added to react at 4 ° C for 1 hour to fix the cells and analyze the expression of related proteins.

接著,加入5 μL之10% Triton X-100於4℃作用5分鐘後,進行離心去除上清液,加入如第4表之一級抗體於4℃反應24小時。然後,加入FITC二級抗體(1:500)避光於室溫下反應3小時。隨後,將細胞液移至FACS專用的試管中,使用流式細胞分析儀,經由雷射光激發產生之綠色波長螢光(FL1 LOG)分析10000顆細胞,配合Winmdi電腦軟體來分析經化合物作用後,各種蛋白之螢光表現量並進行定量,其結果如第5C圖之所示。Next, 5 μL of 10% Triton X-100 was added and the mixture was allowed to act at 4 ° C for 5 minutes, and then the supernatant was removed by centrifugation, and a primary antibody such as the fourth panel was added and reacted at 4 ° C for 24 hours. Then, FITC secondary antibody (1:500) was added to avoid light and react at room temperature for 3 hours. Subsequently, the cell liquid was transferred to a FACS-dedicated test tube, and 10,000 cells were analyzed by a green wavelength fluorescence (FL1 LOG) generated by laser light excitation using a flow cytometer, and analyzed by the Winmdi computer software after the action of the compound. The amount of fluorescent expression of various proteins was quantified, and the results are shown in Fig. 5C.

請參閱第5C圖,其係顯示利用實施例一之牡丹皮苷D對於B16細胞株於黑色素生成時之相關蛋白表現的三維曲線圖,其中x軸代表螢光強度,y軸代表不同組別,z軸代 表細胞數。y軸由近到遠分別為第1道至第6道,其中第1道表示陰性控制組(未經任何處理之B16細胞株)黑色素生成相關蛋白質的表現量,第2道表示經α-MSH處理之控制組細胞之黑色素生成相關蛋白質的表現量,第3道表示實驗組細胞(經α-MSH與5μM之牡丹皮苷D處理)之黑色素生成相關蛋白質的表現量,第4道表示實驗組細胞(經α-MSH與25μM之牡丹皮苷D處理)之黑色素生成相關蛋白質的表現量,第5道表示實驗組細胞(經α-MSH與50μM之牡丹皮苷D處理)之黑色素生成相關蛋白質的表現量,第6道表示實驗組細胞(經α-MSH與100μM之牡丹皮苷D處理)之黑色素生成相關蛋白質的表現量。Please refer to FIG. 5C, which is a three-dimensional graph showing the expression of related proteins of the B16 cell line in the melanin production by using the peony saponin D of the first embodiment, wherein the x-axis represents the fluorescence intensity and the y-axis represents the different groups. Z-axis generation The number of cells in the table. The y-axis is from the first to the sixth, respectively, from the first to the sixth, wherein the first track represents the expression of melanin-related protein in the negative control group (B16 cell line without any treatment), and the second channel represents α-MSH. The expression level of the melanin-producing protein in the control group cells was treated, and the third lane indicates the expression level of the melanin-producing protein in the experimental group cells (treated by α-MSH and 5 μM of peponin D), and the fourth lane indicates the experimental group. The expression of melanin-producing proteins in cells (treated with α-MSH and 25 μM of puerarin D), and the fifth lane indicates melanin-producing proteins of experimental cells (treated with α-MSH and 50 μM of peponin D) The amount of expression, lane 6 indicates the amount of melanin production-related protein in the experimental group cells (treated with α-MSH and 100 μM of puerarin D).

由第5C圖可知,相較於控制組,實驗組之於100μM之牡丹皮苷D作用72小時後,其MC1R、MITF、酪胺酸酶、TRP-1、TRP-2之表現降低,證實實施例一之牡丹皮苷D可抑制細胞內黑色素生成時之相關蛋白表現量,有助於達到抑制細胞內黑色素生成之目的。As can be seen from Fig. 5C, the performance of MC1R, MITF, tyrosinase, TRP-1, and TRP-2 was decreased after 72 hours of treatment with 100 μM of peony glucoside D in the experimental group compared with the control group. Example 1, pepiside D can inhibit the expression of related proteins in the production of melanin in cells, and help to inhibit the production of melanin in cells.

實施例四:評估牡丹皮苷D保護皮膚細胞之能力Example 4: Evaluation of the ability of pepiside D to protect skin cells

此實施例係利用實施例一之牡丹皮苷D,進一步評估對於經照射能量10 J/m2 、20 J/m2 或50 J/m2 之UVB照射後的皮膚細胞之保護能力。This example uses the peony saponin D of Example 1 to further evaluate the protective ability of skin cells after UVB irradiation with an irradiation energy of 10 J/m 2 , 20 J/m 2 or 50 J/m 2 .

1.評估(I)-細胞存活率1. Assessment (I) - cell viability

首先,將HaCaT細胞株與Hs68細胞株,以1.5×105 /mL之細胞濃度接種於96孔盤中培養24小時後,移除細胞上清液,更換無血清之新鮮培養液,置於細胞培養箱中培養。 培養4小時後,移除上清液並以PBS潤洗後抽乾。接著,利用不同照射能量(10、20、50 J/m2 )之UVB照射或者不照射(即控制組)上述細胞後,立即於96孔盤之每孔細胞中加入無血清之新鮮培養液繼續培養4小時,其中此無血清之培養液係未添加(即UVB控制組,只照射UVB)或添加5μM、25μM、50μM、100μM實施例一之牡丹皮苷D(即實驗組,照射UVB後添加牡丹皮萃取物)。然後,利用實施例二之MTT法評估細胞存活率,並於光學顯微鏡影像系統觀察細胞型態之變化,其細胞存活率之結果如第6A圖與第6B圖之所示。First, the HaCaT cell line and the Hs68 cell line were seeded in a 96-well plate at a cell concentration of 1.5 × 10 5 /mL for 24 hours, and then the cell supernatant was removed, and the serum-free fresh medium was replaced and placed in the cell. Culture in an incubator. After 4 hours of culture, the supernatant was removed, rinsed with PBS, and drained. Next, after UVB irradiation with different irradiation energies (10, 20, 50 J/m 2 ) or no irradiation (ie, control group) of the above cells, immediately add serum-free fresh medium to each well of the 96-well plate to continue. The culture was carried out for 4 hours, wherein the serum-free medium was not added (ie, the UVB control group was irradiated only with UVB) or 5 μM, 25 μM, 50 μM, and 100 μM of the peony saponin D of Example 1 (ie, the experimental group was added after irradiation with UVB). Mudan peel extract). Then, the cell survival rate was evaluated by the MTT method of Example 2, and the change in cell type was observed in an optical microscope imaging system, and the results of cell viability were as shown in Figs. 6A and 6B.

請參閱第6A圖與第6B圖,其係繪示利用實施例一之牡丹皮苷D對於經UVB照射後之HaCaT細胞株(第6A圖)以及Hs68細胞株(第6B圖)的細胞存活率曲線圖,其中橫軸為不同UVB之照射能量(J/m2 )下使用不同劑量之牡丹皮萃取物,縱軸為細胞存活率(%)。Please refer to FIGS. 6A and 6B for cell viability of the HaCaT cell line (Fig. 6A) and Hs68 cell line (Fig. 6B) after treatment with UVB using the peony saponin D of Example 1. The graph, in which the horizontal axis is the irradiation energy of different UVB (J/m 2 ), the different doses of the peony bark extract are used, and the vertical axis is the cell survival rate (%).

由第6A圖與第6B圖之結果可知,在使用相同UVB照射能量下,隨著實施例一之牡丹皮萃取物的作用濃度增加,明顯整體提升HaCaT細胞株以及Hs68細胞株的細胞存活率。From the results of Figs. 6A and 6B, it was found that with the same UVB irradiation energy, as the concentration of the effect of the peony bark extract of Example 1 was increased, the cell survival rate of the HaCaT cell line and the Hs68 cell line was significantly increased as a whole.

其次,在UVB控制組中(只照射UVB),隨著UVB照射能量增加,Hs68細胞株隨著UVB照射能量增加而呈現逐漸下降之趨勢,然而HaCaT細胞株之細胞存活率雖有下降但無此趨勢。Secondly, in the UVB control group (UVB only), as the UVB irradiation energy increased, the Hs68 cell line showed a gradual decline with the increase of UVB irradiation energy. However, the cell survival rate of HaCaT cell line decreased, but no such trend.

再者,在實驗組中(照射UVB後添加50 μM或100 μM實施例一之牡丹皮苷D),隨著實施例一之牡丹皮苷D濃度 的增加,明顯降低經UVB照射後的HaCaT細胞中所引起之光毒性反應。以UVB照射能量10 J/m2 為例,相較於只經UVB照射之實驗組(UVB照射能量為10 J/m2 ,實施例一之牡丹皮苷D為0 μM),隨著實施例一之牡丹皮苷D之作用濃度增加,具明顯提升細胞存活率,如第6A圖之所示。然而,在相同UVB照射能量10 J/m2 之下,實施例一之牡丹皮萃取物於Hs68細胞中之試驗結果並未呈現此一趨勢,如第6B圖所示。因此,以下選擇HaCaT細胞評估實施例一之牡丹皮苷D之DNA保護及促進DNA複製的能力。Furthermore, in the experimental group (50 μM or 100 μM of the peony saponin D of Example 1 after UVB irradiation), the HaCaT cells after UVB irradiation were significantly reduced as the concentration of peponin D in Example 1 was increased. The phototoxic reaction caused by it. Taking UVB irradiation energy 10 J/m 2 as an example, compared with the experimental group irradiated only by UVB (UVB irradiation energy is 10 J/m 2 , the peony saponin D of Example 1 is 0 μM), with the examples The concentration of peony saponin D increased, which significantly increased cell viability, as shown in Figure 6A. However, under the same UVB irradiation energy of 10 J/m 2 , the test results of the peony bark extract of Example 1 in Hs68 cells did not exhibit this trend, as shown in Fig. 6B. Therefore, the following HaCaT cells were selected to evaluate the DNA protection of peony saponin D of Example 1 and the ability to promote DNA replication.

2.評估(II)-彗星試驗2. Evaluation (II) - Comet test

彗星試驗分析法係於螢光顯微鏡下,利用單細胞膠體電泳法(single cell gel electrophoresis;SCGE)直接偵測單一細胞中DNA損傷程度,藉此評估實施例一之牡丹皮萃取物。The comet assay analysis method was performed under a fluorescent microscope, and the degree of DNA damage in a single cell was directly detected by single cell gel electrophoresis (SCGE), thereby evaluating the peony bark extract of Example 1.

首先,將HaCaT細胞株以1.5×105 /mL之密度接種於3 cm2 之培養盤中。培養24小時後,分成控制組(未照射UVB亦未與牡丹皮苷D反應)、UVB控制組(只照射UVB但未與牡丹皮苷D反應)以及實驗組〔照射UVB前後與50 μM(實驗組I)或100 μM(實驗組II)之牡丹皮苷D反應4小時〕。其中,UVB控制組與實驗組係利用與上述實施例三的評估(I)之相同條件進行照射UVB,實驗組於UVB照射前與牡丹皮苷D反應係用以評估其對於DNA之保護能力,而於UVB照射後再與牡丹皮苷D反應則用以評估其對於DNA之修復能力。然後,上述各組細胞進行以下單細胞膠體電泳之DNA損傷評估。First, the HaCaT cell strain was seeded at a density of 1.5 × 10 5 /mL in a 3 cm 2 culture dish. After 24 hours of culture, it was divided into control group (no UVB or no reaction with peponin D), UVB control group (UVB only but not with peponin D) and experimental group (50 μM before and after UVB irradiation) Group I) or 100 μM (experimental group II) of pepiside D was reacted for 4 hours]. Among them, the UVB control group and the experimental group were irradiated with UVB under the same conditions as the evaluation (I) of the above Example 3, and the experimental group was reacted with peponin D before UVB irradiation to evaluate its protective ability against DNA. The reaction with peony glucoside D after UVB irradiation was used to evaluate its ability to repair DNA. Then, each of the above groups of cells was subjected to the following DNA damage assessment by single cell colloidal electrophoresis.

上述各組達反應時間後,分別收集上清液至15 mL離心管,再利用胰蛋白酶(trypsin,1×)取下細胞,經離心移除上清液後,加入1 mL之PBS再分散細胞,取其中的100 μL以全自動細胞計數器(例如商品名Countess® automatic cell counter,Invitrogen CountessTM ,)計數細胞密度及存活度,另取500 μl之細胞液與1 μL之溴化乙啶(ethidium bromide;EtBr)混合放置4℃作用5分鐘。接下來,取已塗佈明膠之玻片(FEA,Microscope slides ground edges,厚度1-1.2 mm)滴上300 μl 0.75%一般熔點瓊脂醣(normal melting agarose;NMA),蓋上蓋玻片於4℃放置5分鐘後,取100 μl、體積比1:1之細胞液與0.5%低熔點瓊脂醣(low melting agarose;LMA)的混合物,加至0.75% NMA上,蓋上蓋玻片並於4℃放置5分鐘。然後,再加上100 μl 0.5% LMA,蓋上蓋玻片於4℃放置5分鐘。After the above reaction time was reached, the supernatant was separately collected into a 15 mL centrifuge tube, and the cells were removed by trypsin (1×). After removing the supernatant by centrifugation, 1 mL of PBS was added to redisperse the cells. 100 μL of the cells were counted for cell density and viability using a fully automated cell counter (eg, the brand name Countess® automatic cell counter, Invitrogen CountessTM ) , and 500 μl of cell fluid and 1 μL of ethidium bromide (ethidium) were taken. Bromide; EtBr) was mixed and allowed to stand at 4 ° C for 5 minutes. Next, apply gelatinized slides (FEA, Microscope slides ground edges, thickness 1-1.2 mm) to 300 μl of 0.75% normal melting agarose (NMA) and cover the coverslip at 4 °C. After standing for 5 minutes, a mixture of 100 μl of a 1:1 volume of cell fluid and 0.5% low melting agarose (LMA) was added to 0.75% NMA, covered with a coverslip and placed at 4 ° C. 5 minutes. Then, add 100 μl of 0.5% LMA, cover with a cover glass and leave at 4 ° C for 5 minutes.

而後,將前述玻片完全浸泡於溶解緩衝溶液(lysing buffer;含2.5 M NaCl,100 mM EDTA,100 Mm Tris-HCl,10% DMSO,1% Triton X100)中,並於4℃放置1小時,使細胞膜破裂。Then, the slide was completely immersed in a lysing buffer (2.5 M NaCl, 100 mM EDTA, 100 Mm Tris-HCl, 10% DMSO, 1% Triton X100) and allowed to stand at 4 ° C for 1 hour. The cell membrane is broken.

然後,前述玻片浸泡於酵素緩衝溶液(enzyme reaction buffer;含40 mM Hepes,0.1 M KCl,0.5mM EDTA,and 0.2 mg/ml BSA,adjusted to pH 8 with KOH)4℃放置15分鐘,以去除細胞膜及核膜等大部份的蛋白質。Then, the slide was immersed in an enzyme reaction buffer (40 mM Hepes, 0.1 M KCl, 0.5 mM EDTA, and 0.2 mg/ml BSA, adjusted to pH 8 with KOH) at 4 ° C for 15 minutes to remove Most of the proteins such as cell membranes and nuclear membranes.

之後,前述玻片再浸泡於鹼性緩衝溶液(alkaline buffer;含0.3M NaOH and 1 mMm EDTA in deionized water,pH 13.5)4℃放置15分鐘,使雙股DNA展開形成單股, 以增加分析的敏感性。Thereafter, the slides were further immersed in an alkaline buffer solution (alkaline buffer; containing 0.3 M NaOH and 1 mMm EDTA in deionized water, pH 13.5) at 4 ° C for 15 minutes to expand the double-stranded DNA to form a single strand. To increase the sensitivity of the analysis.

隨後,將前述玻片置於DNA電泳槽中,於4℃且避光的環境下,進行電泳30分鐘後,於螢光顯微鏡(400x)下觀察玻片內細胞的DNA。若細胞DNA產生片斷化等損傷,則斷裂之DNA會移出細胞外而形成拖尾的現象,此時可觀察到DNA具有頭部與尾部,並可觀察到呈現彗星影像。Subsequently, the slide was placed in a DNA electrophoresis tank, and electrophoresis was carried out for 30 minutes at 4 ° C in a dark environment, and the DNA of the cells in the slide was observed under a fluorescence microscope (400 x). If the DNA of the cell is fragmented or the like, the broken DNA will move out of the cell to form a tailing phenomenon. At this time, the DNA has a head and a tail, and a comet image can be observed.

從上述玻片中取相同條件之二重複玻片,各別隨機計數500顆細胞的損傷比例,並隨機取樣25顆呈現彗星型態之細胞進行螢光影像儲存分析。然後,利用市售分析軟體(例如CASP-Comet Assay Software Project,CASPlab),根據頭部長度(head length)、尾部長度(tail length)、頭部亮度(head intensity;或稱頭部DNA量)、尾部亮度(tail intensity;或稱尾部DNA量)等參數,分別計算出頭部DNA百分比{或稱頭部亮度百分比;head DNA intensity(%);即〔頭部亮度/(頭部亮度+尾部亮度)×100〕}、尾部DNA百分比{或稱尾部亮度百分比;tail DNA intensity(%);即〔尾部亮度/(頭部亮度+尾部亮度)×100〕}以及尾動量(tail moment;即(尾部長度×尾部DNA百分比)〕。倘若上述所得之尾部長度百分比、尾部亮度百分比以及尾動量之數值愈高,表示DNA的損傷愈嚴重,其結果如第7A圖與第7B圖之所示。The slides of the same conditions were taken from the above slides, and the damage ratio of 500 cells was randomly counted, and 25 cells with comet-type cells were randomly sampled for fluorescence image storage analysis. Then, using commercially available analytical software (such as CASP-Comet Assay Software Project, CASPlab), according to head length, tail length, head intensity (or head amount of DNA), Parameters such as tail intensity (or tail DNA amount), respectively calculate the percentage of head DNA {or head brightness percentage; head DNA intensity (%); that is, [head brightness / (head brightness + tail brightness) ×100〕}, the percentage of tail DNA {or the percentage of tail brightness; tail DNA intensity (%); that is, [tail brightness / (head brightness + tail brightness) × 100]} and tail moment (tail moment) × Peripheral DNA percentage)]. The higher the value of the tail length percentage, the tail brightness percentage, and the tail momentum obtained above, the more serious the DNA damage, and the results are shown in Figs. 7A and 7B.

請參閱第7A圖,其係顯示利用實施例一之牡丹皮苷D處理並經UVB照射後之HaCaT細胞株的彗星試驗照片,其中第7A圖之參考線長為50μm。在第7A圖中,由上第一行左側起第1張照片代表控制組。由上第一行左側起第 2張至第4張照片代表UVB控制組經UVB照射後的結果。由上第二行與第三行照片代表實驗組經UVB照射後的結果。每張照片左上角或右上角的方塊係放大顯示該照片隨機取樣之細胞DNA型態。Please refer to Fig. 7A, which is a photograph of a comet assay of HaCaT cell line treated with the peony saponin D of Example 1 and irradiated with UVB, wherein the reference line length of Fig. 7A is 50 μm. In Fig. 7A, the first picture from the left side of the first line represents the control group. From the left side of the first line The 2 to 4 photographs represent the results of UVB irradiation in the UVB control group. The results of the second and third rows of photographs represent the results of the experimental group after UVB irradiation. The square in the upper left or upper right corner of each photo magnifies the DNA pattern of the cells randomly sampled.

由第7A圖結果顯示,隨著UVB照射能量增加,細胞DNA受損而造成的拖尾現象就越顯著,如第7A圖UVB控制組(即第一行左側起第2張至第4張照片)所示。其次,隨著實施例一之牡丹皮苷D的添加量增加,可有效減少DNA損傷所形成的彗星拖尾現象,如第7A圖實驗組(即第二行至第三行的照片)所示,證明實施例一之牡丹皮苷D具保護與修復皮膚細胞的能力。第7A圖之DNA受損的細胞經統計後,其結果如第7B圖所示。The results from Figure 7A show that as the UVB irradiation energy increases, the tailing phenomenon caused by damage to the cellular DNA is more pronounced, as in the UVB control group of Figure 7A (ie, the second to fourth photos from the left side of the first line). ) shown. Secondly, with the increase of the addition amount of pepiside D in the first embodiment, the comet tailing phenomenon caused by DNA damage can be effectively reduced, as shown in the experimental group (Fig. 7 to the third row) of Fig. 7A. It is proved that the peony saponin D of the first embodiment has the ability to protect and repair skin cells. After the DNA damaged cells of Fig. 7A were counted, the results are shown in Fig. 7B.

請參閱第7B圖,其係繪示利用實施例一之牡丹皮苷D處理並經UVB照射後之HaCaT細胞株之DNA受損的細胞數直方圖,其中橫軸為UVB的照射劑量,縱軸為每1000個細胞中DNA受損之細胞數,而控制組代表未經UVB照射之HaCaT細胞。Please refer to FIG. 7B, which is a histogram showing the number of damaged cells of the HaCaT cell line treated with the peony saponin D of Example 1 and irradiated with UVB, wherein the horizontal axis is the irradiation dose of UVB, and the vertical axis. The number of cells damaged by DNA per 1000 cells, and the control group represents HaCaT cells that were not irradiated with UVB.

由第7B圖之結果可知,隨著實施例一之牡丹皮苷D的添加量增加,可有效減少DNA受損的細胞數,證明實施例一之牡丹皮苷D具有保護細胞DNA的能力。As is apparent from the results of Fig. 7B, as the amount of the addition of pepiside D in the first embodiment was increased, the number of cells damaged by DNA was effectively reduced, and it was confirmed that the peony saponin D of Example 1 has the ability to protect cellular DNA.

3.評估(III)-細胞週期3. Assessment (III) - Cell Cycle

此實施例係進一步評估實施例一之牡丹皮苷D對於細胞週期的影響。概言之,細胞週期分析主要定量分析DNA含量及倍體狀態,利用可穿透細胞膜之螢光染劑〔例如紅色的碘化丙啶(propidium iodide;PI)染劑溶液〕,將染劑 分子嵌入DNA分子後,藉由流式細胞儀觀察波長488 nm之紅色螢光強度。當細胞受損或進行凋亡時,DNA會斷裂片斷化而游離於細胞外,此時細胞內嵌入PI的DNA含量則降低,導致相對螢光強度亦減弱,藉此可評估細胞凋亡程度。This example further evaluates the effect of the peony saponin D of Example 1 on the cell cycle. In summary, the cell cycle analysis mainly quantitatively analyzes the DNA content and the ploidy state, and uses a fluorescent dye that can penetrate the cell membrane (for example, a red propidium iodide (PI) dye solution) to dye the dye. After the molecules were embedded in the DNA molecule, the red fluorescence intensity at a wavelength of 488 nm was observed by flow cytometry. When the cells are damaged or undergo apoptosis, the DNA is fragmented and released outside the cell. At this time, the DNA content of the cells embedded in the PI is decreased, and the relative fluorescence intensity is also weakened, thereby evaluating the degree of apoptosis.

首先,HaCaT細胞株與Hs68細胞株係以1.5×105 /mL之密度接種於3 cm2 之培養盤中。培養24小時後,分成控制組(未照射UVB亦未與牡丹皮苷D反應)、UVB控制組(只照射UV但未與牡丹皮苷D反應)以及實驗組(照射UVB前後均與牡丹皮苷D反應),其中實驗組於照射UVB前係與50 μM(實驗組I)或100 μM(實驗組II)之牡丹皮苷D反應4小時,經照射2小時或4小時之UVB後,再與相同濃度之牡丹皮苷D反應2小時或4小時。First, HaCaT cell line and Hs68 cell line were seeded at a density of 1.5 × 10 5 /mL in a 3 cm 2 culture dish. After 24 hours of culture, it was divided into control group (no UVB and no reaction with peponin D), UVB control group (only UV was irradiated but not reacted with pepiside D), and experimental group (both erythroside before and after UVB irradiation) D reaction), in which the experimental group was reacted with 50 μM (experimental group I) or 100 μM (experimental group II) of pepiside D for 4 hours before UVB irradiation, after UVB irradiation for 2 hours or 4 hours, and then The same concentration of pepiside D was reacted for 2 hours or 4 hours.

上述各組達反應時間後,分別收集上清液至15 mL離心管,再利用胰蛋白酶(trypsin,1×)取下細胞,經離心移除上清液後,加入300 μl之PBS再分散細胞。接著,緩慢震盪滴入700 μl之99.9%酒精固定細胞,使最終酒精濃度為70%之細胞固定液,置於4℃固定24小時。然後,以1200 rpm之轉速離心5分鐘、移除酒精固定液後,加入445 μL之PBS使細胞均勻分散,再加入5 μL之RNase(10 mg/mL)以及50 μL之10% Triton X-100溶液,於37℃反應30分鐘分解RNA。之後,離心5分鐘、移除上清液後,加入500 μl PBS分散細胞,再加入5 μL之碘化丙啶(propidium iodide;PI)染劑溶液進行DNA染色,置於4℃避光反應15分鐘。隨後,利用0.45 μm之濾膜過濾細胞液並收集於流 式細胞分選儀(fluorescence-activated cell sorter;FACS)專用的試管中,使用市售流式細胞分析儀(Flow cytometer),例如FACScanTM 系統(FACScanTM system;Becton Dickson),經由雷射光激發產生之紅色波長螢光(例如參數設定為FL3 LIN),分析10000顆細胞,配合Winmdi電腦軟體分析細胞週期的分佈,並依細胞週期Sub-G1 、G0 /G1 、S、G2 /M進行數值定量分析,其結果如第8圖所示。After the above reaction time was reached, the supernatant was separately collected into a 15 mL centrifuge tube, and the cells were removed by trypsin (1×). After removing the supernatant by centrifugation, 300 μl of PBS was added to redisperse the cells. . Next, 700 μl of 99.9% alcohol-fixed cells were slowly shaken, and a cell fixed solution having a final alcohol concentration of 70% was placed and fixed at 4 ° C for 24 hours. Then, centrifuge at 1200 rpm for 5 minutes, remove the alcohol fixative, add 445 μL of PBS to evenly disperse the cells, add 5 μL of RNase (10 mg/mL) and 50 μL of 10% Triton X-100. The solution was reacted at 37 ° C for 30 minutes to decompose RNA. After centrifugation for 5 minutes, remove the supernatant, add 500 μl of PBS to disperse the cells, add 5 μL of propidium iodide (PI) dye solution for DNA staining, and place at 4 ° C in the dark. minute. Subsequently, the cell membrane filter of 0.45 μm and collected in a liquid flow sorter (fluorescence-activated cell sorter; FACS ) dedicated tubes, using a commercially available flow cytometry (Flow cytometer), e.g. FACScan TM System (FACScan TM system; Becton Dickson), red wavelength fluorescence generated by laser excitation (for example, parameter set to FL3 LIN), analysis of 10,000 cells, analysis of cell cycle distribution with Winmdi computer software, and cell cycle Sub- G 1 , G 0 /G 1 , S, and G 2 /M were numerically analyzed, and the results are shown in Fig. 8.

請參閱第8圖,其係顯示利用實施例一之牡丹皮苷D對於經或未經UVB照射之HaCaT細胞株的細胞週期分佈圖,其中第8圖之橫軸代表時間,而縱軸為細胞對數值。在第8圖中,由上第一行左側起第1張與第二行左側起第1張照片皆顯示控制組的細胞週期分佈圖。由上第一行左側起第2張與第二行左側起第2張照片皆顯示UVB控制組的細胞週期分佈圖。由上第一行左側起第3~4張與第二行左側起第3~4張照片皆顯示實驗組的細胞週期分佈圖。Please refer to Fig. 8, which shows the cell cycle distribution of the HaCaT cell line treated with or without UVB using the peony saponin D of Example 1, wherein the horizontal axis of Figure 8 represents time and the vertical axis represents cells. Logarithmic value. In Fig. 8, the first photograph from the left side of the first line and the left side of the second line shows the cell cycle distribution map of the control group. The second cycle from the left of the first row to the left and the second from the left of the second row show the cell cycle distribution of the UVB control group. The cell cycle distribution of the experimental group is shown in the third to fourth photos from the left side of the first line and the third to fourth pictures from the left side of the second line.

由第8圖結果顯示,相較於控制組,UVB控制組細胞在UVB照射後之2小時,其細胞的G0 /G1 期下降,但Sub-G1 和S期增加。UVB照射後之4小時亦有一致的結果,其中UVB控制組細胞在UVB照射後之4小時,其細胞的G0 /G1 期持續下降,但Sub-G1 和G2 /M期亦上升。然而,當實施例一之牡丹皮苷D加入實驗組細胞後,相較於UVB控制組,實驗組細胞隨著反應時間,顯著提升其S-G2 /M之DNA合成期,但Sub-G1 期則有降低之趨勢,證明實施例一之牡丹皮苷D確實可影響細胞週期分佈,並提升其S-G2 /M之DNA合成期。From the results of Fig. 8, it was revealed that the cells of the UVB control group had a decrease in the G 0 /G 1 phase of the cells 2 hours after UVB irradiation, but the Sub-G 1 and S phases increased compared with the control group. There was also a consistent result 4 hours after UVB irradiation. In the UVB control group, the G 0 /G 1 phase of the cells continued to decrease 4 hours after UVB irradiation, but the Sub-G 1 and G 2 /M phases also increased. . However, when the peony saponin D of Example 1 was added to the experimental group, compared with the UVB control group, the cells of the experimental group significantly increased the DNA synthesis phase of SG 2 /M with the reaction time, but Sub-G phase 1 There is a tendency to decrease, demonstrating that the peony saponin D of Example 1 does affect cell cycle distribution and enhances the DNA synthesis phase of SG 2 /M.

4.評估(IV)-BrdU免疫螢光染色4. Evaluation (IV)-BrdU immunofluorescence staining

細胞在進行DNA合成時,添加胸腺嘧啶(thymidine)之類似物,例如5-溴脫氧尿嘧啶核苷(5-bromo-deoxy-uridine;BrdU),可造成配對錯誤(misincorporation)而嵌入DNA中,藉此可標定DNA並偵測活細胞中DNA合成的活性。倘若細胞增殖時複製DNA的過程中,可摻入新合成的DNA序列,取代胸腺嘧啶(T),則可藉由BrdU-FITC之螢光含量,偵測化合物是否具細胞增殖作用。When cells are subjected to DNA synthesis, an analog of thymidine, such as 5-bromo-deoxy-uridine (BrdU), may be added to cause misincorporation and insertion into the DNA. Thereby, DNA can be calibrated and the activity of DNA synthesis in living cells can be detected. In the process of replicating DNA during cell proliferation, a newly synthesized DNA sequence can be incorporated to replace thymine (T), and the fluorescence content of BrdU-FITC can be used to detect whether the compound has a cell proliferation effect.

首先,將HaCaT細胞株與Hs68細胞株以1.5×105 /mL之密度,分別接種於96孔盤之每孔中。培養24小時後,分成控制組(未照射UVB亦未與牡丹皮苷D反應)以及多個實驗組(包括照射0、10 J/m2 、20 J/m2 、50 J/m2 之UVB後,分別與0、5 μM、25 μM、50 μM、100 μM之牡丹皮苷D反應4小時)。上述之UVB控制組與實驗組係利用與上述實施例三的評估(I)之相同條件進行照射UVB。First, HaCaT cell line and Hs68 cell line were seeded at a density of 1.5 × 10 5 /mL, respectively, in each well of a 96-well plate. After 24 hours of culture, it was divided into control group (no UVB and no reaction with peponin D) and multiple experimental groups (including UVB irradiated with 0 , 10 J/m 2 , 20 J/m 2 , 50 J/m 2 ) . Thereafter, it was reacted with 0, 5 μM, 25 μM, 50 μM, 100 μM of puerarin D for 4 hours). The UVB control group and the experimental group described above were irradiated with UVB under the same conditions as the evaluation (I) of the above Example 3.

上述各組達反應時間後,利用PBS潤洗細胞。接著,於每孔細胞中加入50 μL、100%之冰甲醇(methanol),於4℃反應10分鐘固定細胞。然後,移除上清液並風乾1小時,再加入1%(w/v)之胎牛血清白蛋白(bovine serum albumin;BSA),藉以填補細胞間隙降低非專一性結合所產生的背景值。於室溫下均勻搖晃1小時後,移除上清液,於每孔細胞中加入40 μL之一級抗體,放置4℃反應24小時。一級抗體為抗BrdU之小鼠單株抗體(mouse mAb;Santa Cruz Biotechnology;免疫螢光染色之稀釋濃度為1:100)。After each of the above groups reached the reaction time, the cells were washed with PBS. Next, 50 μL of 100% ice methanol was added to each well of the cells, and the cells were fixed by reacting at 4 ° C for 10 minutes. Then, the supernatant was removed and air-dried for 1 hour, and then 1% (w/v) of bovine serum albumin (BSA) was added to fill the cell gap to reduce the background value produced by non-specific binding. After shaking uniformly for 1 hour at room temperature, the supernatant was removed, and 40 μL of the primary antibody was added to each well of the cells, and allowed to react at 4 ° C for 24 hours. The primary antibody was a monoclonal antibody against mouse BrdU (mouse mAb; Santa Cruz Biotechnology; dilution concentration of immunofluorescence staining was 1:100).

之後,利用PBS清洗細胞二次,加入結合螢光之FITC 二級抗體,於室溫下避光反應3小時。而後,利用PBS清洗兩次,於每孔加入100 μL之PBS,以酵素免疫分析儀(BioTek,SynergyTM 2,USA)偵測FITC(Excitation:485 nm,Emission:528 nm)之螢光量;再於每孔加入10 μL、比例1:250的Hoechst 33342染劑溶液(10 μg/mL),均勻混合後,於顯微鏡下觀察細胞核染色。隨後,移除上清液,並於每孔加入100 μL之PBS,利用酵素免疫分析儀(BioTek,SynergyTM 2,USA)偵測Hoechst 33342(Excitation:360 nm,Emission:460 nm)細胞中抗原抗體結合產生之螢光表現,並計算其螢光比例,其結果如第9A圖至第9C圖。Thereafter, the cells were washed twice with PBS, and a fluorescent-conjugated FITC secondary antibody was added thereto, and the reaction was allowed to stand at room temperature for 3 hours in the dark. Then, it was washed twice with PBS, 100 μL of PBS was added to each well, and the amount of fluorescence of FITC (Excitation: 485 nm, Emission: 528 nm) was detected by an enzyme immunoassay analyzer (BioTek, Synergy TM 2, USA); 10 μL of a 1:250 Hoechst 33342 dye solution (10 μg/mL) was added to each well, and after uniform mixing, nuclear staining was observed under a microscope. Subsequently, the supernatant was removed, and 100 μL of PBS was added to each well, and the antigen in Hoechst 33342 (Excitation: 360 nm, Emission: 460 nm) cells was detected by an enzyme immunoassay analyzer (BioTek, Synergy TM 2, USA). The fluorescent expression produced by antibody binding was calculated and the fluorescence ratio was calculated. The results are shown in Figures 9A to 9C.

請參閱第9A圖與第9B圖,其係分別顯示利用實施例一之牡丹皮苷D對於經或未經UVB照射之HaCaT細胞株(第9A圖)與Hs68細胞株(第9B圖)的BrdU螢光強度直方圖,其中橫軸代表控制組與不同條件的實驗組,而縱軸代表不同BrdU螢光強度(%)。Please refer to Fig. 9A and Fig. 9B, respectively, showing BrdU of HacaT cell line (Fig. 9A) and Hs68 cell line (Fig. 9B) using the peony saponin D of Example 1 for or without UVB irradiation. Fluorescence intensity histogram, where the horizontal axis represents the control group and the experimental group with different conditions, and the vertical axis represents the different BrdU fluorescence intensity (%).

第9C圖則顯示利用實施例一之牡丹皮苷D對於HaCaT細胞株經免疫螢光染色之細胞照片(放大倍率為200倍),其中,第9C圖由左側算起第一排(直)的照片為相位差光學顯微鏡觀察到之HaCaT細胞影像,第二排(直)照片為Hoechst 33342螢光染色觀察到之HaCaT細胞核影像,而第三排(直)照片為BrdU螢光染色觀察到之HaCaT細胞株的DNA影像。由上左側算起第一列(橫)第1張至第3張照片代表控制組,第二列(橫)第1張至第3張照片代表UVB控制組,第三列(橫)第1張至第3張代表實驗組。每張照片角落較大的方塊係放大顯示中間較小方塊內隨機取樣之 細胞型態。Fig. 9C is a photograph showing the cells of the HaCaT cell line stained with immunofluorescence using the peony saponin D of Example 1 (magnification: 200 times), wherein the 9C chart is counted from the left side (straight) The photographs are HaCaT cell images observed by phase contrast optical microscopy, the second row (straight) photographs are HaCaT nuclear images observed by Hoechst 33342 fluorescent staining, and the third row (straight) photographs are HaCaT observed by BrdU fluorescent staining. DNA image of the cell line. From the upper left side, the first column (horizontal) from the first to the third photo represents the control group, the second column (horizontal) from the first to the third photo represents the UVB control group, and the third column (horizontal) is the first The third piece of Zhang Zhi represents the experimental group. The larger square in each photo is enlarged to show random sampling in the middle smaller square. Cell type.

由第9A圖與第9B圖結果顯示,相較於控制組,隨著UVB照射劑量增加,未與牡丹皮苷D反應之HaCaT細胞株與HaCaT細胞株的BrdU螢光表現顯著下降。然而,HaCaT細胞經與牡丹皮苷D反應後,明顯增加BrdU之螢光含量,尤其UVB之照射劑量為10 J/m2 之實驗組中,牡丹皮苷D明顯提升細胞增殖作用。但是在Hs68細胞株並未觀察到規則的劑量反應(dose response)。From the results of Fig. 9A and Fig. 9B, the BrdU fluorescence of the HaCaT cell line and the HaCaT cell line which did not react with pepiside D was significantly decreased as the UVB irradiation dose was increased as compared with the control group. However, HaCaT cells significantly increased the fluorescence content of BrdU after reacting with pepiside D. Especially in the experimental group with UVB irradiation dose of 10 J/m 2 , pepiside D significantly enhanced cell proliferation. However, no regular dose response was observed in the Hs68 cell line.

其次,由第9C圖結果顯示,相較於UVB控制組(由上左側算起第二列(橫)第1張至第3張照片),實驗組(由上左側算起第三列(橫)第1張至第3張)之HaCaT細胞株因與100 μM之牡丹皮苷D反應,明顯增加BrdU之螢光含量,證明實施例一之牡丹皮苷D可促進DNA進行複製,使BrdU-FITC得以嵌入DNA複製之新合成序列中,大幅提升BrdU之螢光表現。Secondly, the results from the 9C chart show that compared to the UVB control group (the second column (horizontal) from the top left (the first to the third photo)), the experimental group (from the left side of the third column (horizontal The 1st to 3rd HaCaT cell lines significantly increased the fluorescence content of BrdU by reacting with 100 μM of peony glucoside D, demonstrating that the peony glucoside D of Example 1 can promote DNA replication and BrdU- FITC is able to embed the new synthetic sequence of DNA replication, greatly improving the fluorescent performance of BrdU.

綜上所述,由上述評估(II)-彗星試驗、評估(III)-細胞週期、評估(IV)BrdU免疫螢光染色等實驗證實,實施例一之牡丹皮苷D確實具有DNA保護以及促進DNA複製的能力。In summary, the above evaluation (II)-comet assay, evaluation (III)-cell cycle, evaluation (IV) BrdU immunofluorescence staining and other experiments confirmed that the peony glucoside D of Example 1 does have DNA protection and promotion. The ability to replicate DNA.

實施例五:評估牡丹皮苷D修復皮膚細胞之能力Example 5: Evaluation of the ability of peponin D to repair skin cells

此實施例係利用實施例一之牡丹皮苷D,進一步評估對於經UVB照射後的皮膚細胞之修復能力。This example further evaluated the repair ability of skin cells after UVB irradiation using the peony saponin D of Example 1.

1.評估核苷酸切除修復系統之相關基因與蛋白質表現1. Evaluation of related gene and protein expression in nucleotide excision repair system

核苷酸切除修復(NER)系統主要修復因紫外線照射引 起之DNA損傷。當細胞進行NER修復DNA時,目前已知先由XPC結合HR23E蛋白質辨識DNA損傷處,再由TFIIH、XPB和XPD解旋酶使損傷處之DNA鬆散,由XPA和RPA形成複合體結合於DNA損傷處,以促進DNA內切酶XPF/ERCC1剪接5'端和XPG剪切3'端。接著,附著於經剪切之單股DNA上的RPA經CDK2磷酸化後,主要可促進PCNA結合DNA polymerase δ一同填補經切除之DNA損傷片段,進而修復DNA損傷處。Nucleotide excision repair (NER) system mainly repairs due to ultraviolet radiation DNA damage. When cells perform NER repair DNA, it is known that the DNA damage is identified by XPC combined with HR23E protein, and the DNA of the lesion is loosened by TFIIH, XPB and XPD helicase, and the complex formed by XPA and RPA binds to DNA damage. At the 5' end of the cleavage of the DNA endonuclease XPF/ERCC1 and the 3' end of the XPC. Subsequently, phosphorylation of RPA attached to the sheared single-stranded DNA by CDK2 mainly promotes the binding of the PCNA-binding DNA polymerase δ to the resected DNA damage fragments, thereby repairing the DNA damage.

首先,將HaCaT細胞株與Hs68細胞株以1.5×105 /mL之密度,分別接種於6孔盤或10 cm2 之培養皿中。培養24小時後,分成控制組(未照射UVB亦未與牡丹皮苷D反應)、UVB控制組(只照射10 J/m2 之UVB但未與牡丹皮苷D反應)以及實驗組(照射10 J/m2 之UVB前後與牡丹皮苷D反應)。前述UVB控制組與實驗組係利用與上述實施例三的評估(I)之相同條件進行照射10 J/m2 或50 J/m2 之UVB。實驗組於照射UVB前係與50 μM或100 μM之牡丹皮苷D反應4小時(控制組則於無血清之新鮮培養液培養4小時),照射UVB,再與相同濃度之牡丹皮苷D反應2小時、4小時、6小時或8小時(控制組則於無血清之新鮮培養液培養2小時、4小時、6小時)後,測定細胞核苷酸切除修復系統之相關基因與蛋白質表現。First, the HaCaT cell line and the Hs68 cell line were inoculated at a density of 1.5 × 10 5 /mL, respectively, in a 6-well plate or a 10 cm 2 culture dish. After 24 hours of culture, it was divided into control group (no UVB and no reaction with peponin D), UVB control group (only 10 J/m 2 UVB but not with peponin D) and experimental group (irradiation 10) J/m 2 is reacted with peony saponin D before and after UVB). The UVB control group and the experimental group were irradiated with UVB of 10 J/m 2 or 50 J/m 2 under the same conditions as the evaluation (I) of the above Example 3. The experimental group was reacted with 50 μM or 100 μM of pepiside D for 4 hours before irradiation with UVB (the control group was cultured in serum-free fresh medium for 4 hours), irradiated with UVB, and reacted with the same concentration of peponin D. After 2 hours, 4 hours, 6 hours or 8 hours (the control group was cultured for 2 hours, 4 hours, and 6 hours in serum-free fresh medium), the related gene and protein expression of the nucleotide excision repair system were measured.

(1)評估NER系統之相關基因表現(1) Assessment of related gene expression in the NER system

上述接種於6孔盤之各組達反應時間後,分別收集上清液至15 mL離心管,再利用胰蛋白酶(trypsin,1×)取下細胞,經離心移除上清液後,利用習知方法萃取總RNA。 所得之總RNA經定量後,利用同步反轉錄聚合酶鏈鎖反應(real-time reverse-transcription polymerase chain reaction;real-time RT-PCR),檢測實施例一之牡丹皮苷D是否調控NER系統之相關基因表現。After the above reaction time was inoculated in each of the 6-well plates, the supernatant was separately collected into a 15 mL centrifuge tube, and the cells were removed by trypsin (1×), and the supernatant was removed by centrifugation. The method is known to extract total RNA. After the total RNA obtained is quantified, the real-time reverse-transcription polymerase chain reaction (real-time RT-PCR) is used to detect whether the peony saponin D of the first embodiment regulates the NER system. Related gene expression.

上述real-time RT-PCR可參考習知方法或下述方式進行。首先,配製反轉錄反應液,其係利用0.1% DEPC-H2 O將所得之總RNA之濃度調整為2 mg/mL後,將體積補至12.5 μL,並加入1 μL之寡聚胸苷酸〔oligo(dT)〕引子混合均勻,於70℃反應2分鐘。然後,將前述反應混合物迅速置於冰上,再加入4 μL之5倍(5×)莫洛尼氏鼠白血病病毒(moloney murine leukemia virus;MMLV)之反轉錄反應緩衝溶液(MMLV-RT buffer solution)、1 μL之10 mM dNTPs、0.5 μL之核醣核酸酶抑制劑(RNase inhibitor)以及1 μL之MMLV反轉錄酶(MMLV RTase),於42℃反應1小時並於94℃反應5分鐘,以合成cDNA。之後,加入冰的二次去離子水(ddH2 O)將cDNA的體積補足至100 μL,即製備完成cDNA並存放於-80℃。The above real-time RT-PCR can be carried out by referring to a conventional method or the following manner. First, a reverse transcription reaction solution was prepared which adjusted the concentration of the total RNA obtained to 2 mg/mL with 0.1% DEPC-H 2 O, and the volume was made up to 12.5 μL, and 1 μL of oligo-thymidylate was added. [oligo (dT)] The primer was uniformly mixed and reacted at 70 ° C for 2 minutes. Then, the above reaction mixture was quickly placed on ice, and then 4 μL of 5 times (5×) Moloney murine leukemia virus (MMLV) reverse transcription reaction buffer solution (MMLV-RT buffer solution) was added. 1 μL of 10 mM dNTPs, 0.5 μL of RNase inhibitor and 1 μL of MMLV reverse transcriptase (MMLV RTase), reacted at 42 ° C for 1 hour and reacted at 94 ° C for 5 minutes to synthesize cDNA. Thereafter, the volume of cDNA was made up to 100 μL by adding iced deionized water (ddH 2 O), and the cDNA was prepared and stored at -80 °C.

接下來,取上述10 μL之cDNA(約10 ng至50 ng),與12.5 μL之SYBR Green混合物、2.5 μl 10 μM之各基因引子對混合物(包括上游引子與上游引子)以及ddH2 O,混合為總體積25μL之反應溶液。前述各基因適用的上游引子與上游引子之具體例如第5表之所示。Next, take the above 10 μL of cDNA (about 10 ng to 50 ng), mix with 12.5 μL of SYBR Green mixture, 2.5 μl of 10 μM gene primer pair (including upstream primer and upstream primer) and ddH 2 O. A total volume of 25 μL of the reaction solution. Specific examples of the upstream primer and the upstream primer to which the above respective genes are applied are shown, for example, in Table 5.

上述反應溶液經低轉速離心後,進行同步定量PCR(real-time quantitative PCR),其反應條件如下:於95℃進行15秒使雙股模板DNA分離(ds DNA denaturation),於52℃至60℃進行45秒使引子黏合(annealing),於72℃進行1分鐘使DNA延長反應(extension),以此為一個循環,共重複進行40個循環的反應,然後於72℃進行5分鐘。待循環完畢,利用市售軟體,例如amplification plot或其他功能替代的軟體,分析上述所得NER系統之相關基因的螢光強度,其結果如第10A圖之所示。After the above reaction solution was centrifuged at a low rotation speed, real-time quantitative PCR was carried out under the following conditions: separation of the double-stranded template DNA (dDNA denaturation) at 52 ° C for 15 seconds at 52 ° C to 60 ° C The primer was annealed for 45 seconds, and the DNA was extended at 72 ° C for 1 minute to carry out an extension of the DNA, and the reaction was repeated for 40 cycles, and then carried out at 72 ° C for 5 minutes. After the cycle is completed, the fluorescence intensity of the gene related to the NER system obtained above is analyzed using a commercially available software such as an amplification plot or other functional replacement software, and the results are shown in Fig. 10A.

請參閱第10A圖,其係顯示利用實施例一之牡丹皮苷D對於經或未經UVB照射之HaCaT細胞株的核苷酸切除修復系統(NER)之相關基因表現,其中橫軸為HaCaT細胞株與牡丹皮苷D反應的時間(小時),縱軸為NER系統之相 關基因相對於β-肌動蛋白之基因表現量(density ratio;由螢光強度換算而得)。Please refer to FIG. 10A, which shows the related gene expression of the nucleotide excision repair system (NER) of the HaCaT cell line with or without UVB irradiation using the peony saponin D of Example 1, wherein the horizontal axis is HaCaT cells. The time (hours) in which the strain reacts with peponin D, and the vertical axis is the phase of the NER system. Gene expression relative to β-actin (density ratio; obtained from fluorescence intensity).

由第10A圖之結果顯示,相較於控制組,HaCaT細胞株在照射UVB前先與50 μM之牡丹皮苷D反應4小時、且在照射UVB後又與50 μM之牡丹皮苷D反應2小時,可明顯增加其XPC基因的表現量。至於其他基因,例如XPA基因、RPA基因、ERCC1基因、XPF基因、XPG基因及PCNA基因,其表現量亦隨著反應時間增加而增加,顯示實施例一之牡丹皮苷D確實可增加NER系統相關的基因表現量,有助於修復HaCaT細胞經紫外線照射後造成的DNA損傷。From the results of Fig. 10A, the HaCaT cell line was reacted with 50 μM of pepiside D for 4 hours before irradiation with UVB, and reacted with 50 μM of peony saponin D after irradiation with UVB. Hours can significantly increase the amount of XPC gene expression. As for other genes, such as XPA gene, RPA gene, ERCC1 gene, XPF gene, XPG gene and PCNA gene, the expression amount also increased with the increase of reaction time, indicating that the peony saponin D of Example 1 can increase the NER system. The amount of gene expression helps to repair DNA damage caused by HaCaT cells after UV irradiation.

(2)評估NER系統之相關蛋白質表現(I)(2) Evaluation of related protein performance of NER system (I) (2.1)萃取蛋白質(2.1) Extracting proteins

將上述10 cm2 之培養皿各組(實驗組為照射10 J/m2 之UVB後再與相同濃度之牡丹皮苷D反應8小時)達反應時間後,分別收集上清液至15 mL離心管,再利用胰蛋白酶(trypsin,1×)取下細胞,經離心移除上清液後,進行蛋白質萃取,以西方墨點法分析相關蛋白表現。After the reaction time was reached in each of the above 10 cm 2 culture dishes (the experimental group was irradiated with 10 J/m 2 of UVB and then reacted with the same concentration of pepiside D for 8 hours), the supernatant was separately collected to 15 mL for centrifugation. The tube was removed by trypsin (1×), and the supernatant was removed by centrifugation, followed by protein extraction, and the protein expression was analyzed by Western blotting.

首先,可運用習知方法,利用不同濃度的BSA建立標準曲線,再將上述萃取而得之蛋白質的吸光值帶入線性回歸公式,換算出各組的蛋白質濃度。本發明所述之技術領域中具有通常知識者應可熟知建立標準曲線並換算蛋白質濃度,在此不另贅述。First, a standard curve can be established using different concentrations of BSA using a conventional method, and the absorbance of the extracted protein can be brought into a linear regression formula to convert the protein concentration of each group. Those of ordinary skill in the art to which the present invention pertains should be familiar with establishing standard curves and converting protein concentrations, which are not described herein.

(2.2)蛋白質電泳分析(2.2) Protein electrophoresis analysis

接下來,上述各組的蛋白質可利用十二烷基硫酸鈉-聚丙烯醯胺膠體電泳分析(SDS-PAGE electrophoresis assay)進行評估。首先,根據實施例二之第2表製備10%之下層膠(Running gel),然後根據實施例二之第3表製備7.5%上層膠(stacking gel),此處亦不贅言。Next, the proteins of the above groups can be evaluated using a sodium dodecyl sulfate-polyacrylamide colloidal electrophoresis assay (SDS-PAGE electrophoresis assay). First, a 10% running gel was prepared according to the second table of Example 2, and then 7.5% of the stacking gel was prepared according to the third table of Example 2, and it is also not mentioned here.

隨後,取上述各組的蛋白質經換算後,與5×Loading dye buffer以5:1之體積比混合,於100℃處理5分鐘後,移至4℃冷卻備用。Subsequently, the proteins of the above groups were converted, mixed with 5× Loading dye buffer in a volume ratio of 5:1, treated at 100 ° C for 5 minutes, and then moved to 4 ° C for cooling.

將上述製備好的膠片放入市售電泳槽(例如商品名miniVE,Complete,GE-80-6418-77,GE Healthcare,U.S.A.)中,以90伏特之電壓預跑15分鐘至20分鐘。然後,依序加入標準蛋白分子量標記(standard protein MW marker)以及上述各組的蛋白質後,以130伏特之電壓進行電泳分析。The film prepared above was placed in a commercially available electrophoresis tank (for example, trade name miniVE, Complete, GE-80-6418-77, GE Healthcare, U.S.A.), and pre-run for 15 minutes to 20 minutes at a voltage of 90 volts. Then, a standard protein MW marker and a protein of each of the above groups were sequentially added, followed by electrophoresis analysis at a voltage of 130 volts.

然後,將上述SDS-PAGE之電泳膠體取下,進行西方轉漬法分析(Western blotting assay)。首先,將市售轉印膜,例如聚偏二氟乙烯轉印膜(polyvinylidene difluoride membrans,PVDF membrane;例如商品名PolyScreen PVDF Hybridization Transfer Membrane,PK-NEF1002,PerkinElmer,USA)浸泡於甲醇5分鐘,以改變PVDF membrane之極性。接下來,於組合卡匣(Gel holder cassette)中依序放上海綿墊、濾紙以及電泳膠體,再覆蓋PVDF轉印膜,清除其中之氣泡後,再依序放上濾紙、海綿墊並將卡匣蓋上夾緊,置入市售西方轉漬槽(例如商品名Mighty small transphor,TE 22,Amersham biosciences,U.S.A.)中,以60伏特之電壓、200毫安培、於4℃下進行轉漬90分 鐘,將蛋白質轉印至PVDF轉印膜上。之後,將經轉漬完成帶有蛋白質之PVDF轉印膜利用0.1% PBST(Tween-20/PBS)清洗後,即進行特定蛋白質表現之免疫染色。Then, the above-mentioned SDS-PAGE electrophoresis colloid was taken out and subjected to Western blotting assay. First, a commercially available transfer film, such as polyvinylidene difluoride membrans (PVDF membrane; for example, trade name PolyScreen PVDF Hybridization Transfer Membrane, PK-NEF1002, PerkinElmer, USA), is immersed in methanol for 5 minutes to Change the polarity of the PVDF membrane. Next, put the sponge pad, filter paper and electrophoresis gel in the Gel holder cassette, cover the PVDF transfer film, remove the bubbles, and then put the filter paper, sponge pad and card in sequence. The crucible is clamped and placed in a commercially available western transfer tank (for example, trade name Mighty small transphor, TE 22, Amersham biosciences, USA), and subjected to 60 volts at a voltage of 200 volts at 4 ° C. Minute Clock, transfer the protein onto the PVDF transfer film. Thereafter, the PVDF transfer film with protein was completely washed with 0.1% PBST (Tween-20/PBS), and immunostaining of specific protein expression was performed.

上述轉漬完成之PVDF轉印膜浸泡於含有5%脫脂奶粉之0.1% PBST(Tween-20/PBS)中,輕微搖晃作用60分鐘,以進行非特異性抗原阻斷(non-specific antigen blocking)。接著,以0.1% PBST清洗PVDF轉印膜後,利用0.1% PBST配製一級抗體(1:1000),將PVDF轉印膜完全浸泡於一級抗體於4℃下反應至隔夜。然後,再以0.1% PBST清洗PVDF轉印膜,並加入二級抗體(1:1000)於4℃下作用2-3小時。之後,於4℃以0.1% PBST清洗PVDF轉印膜2小時,加入呈色劑與PVDF轉印膜反應3分鐘。而後,再加入顯色劑混合反應,隨即利用冷光影像分析儀(Avegene Life Science,LIAS ChemLite Series,ChemLite 200FA/400FA)儲存影像。前述之冷光影像分析儀可根據儲存的影像,偵測Luminol(Cyclic phthalhydrazides)由基態被激發成激發態、再回復到基態時釋出冷光的強度,並進行定量分析。The above-mentioned PVDF transfer film was immersed in 0.1% PBST (Tween-20/PBS) containing 5% skim milk powder and shaken gently for 60 minutes for non-specific antigen blocking. . Next, after washing the PVDF transfer film with 0.1% PBST, the primary antibody (1:1000) was prepared using 0.1% PBST, and the PVDF transfer film was completely immersed in the primary antibody and reacted at 4 ° C until overnight. Then, the PVDF transfer film was washed with 0.1% PBST, and a secondary antibody (1:1000) was added thereto to act at 4 ° C for 2-3 hours. Thereafter, the PVDF transfer film was washed with 0.1% PBST at 4 ° C for 2 hours, and a coloring agent was added to react with the PVDF transfer film for 3 minutes. Then, a color developer mixing reaction was added, and images were stored using a cold light image analyzer (Avegene Life Science, LIAS ChemLite Series, ChemLite 200FA/400FA). The luminescence image analyzer described above can detect the intensity of Luminol (Cyclic phthalhydrazides) released from the ground state when excited to an excited state and then return to the ground state according to the stored image, and quantitatively analyze.

請參閱第10B圖,其係顯示利用實施例一之牡丹皮苷D對於經或未經UVB照射之HaCaT細胞株的核苷酸切除修復系統(NER)之相關蛋白質表現的西方轉漬法分析圖,其中第1道表示控制組NER相關蛋白質的表現量,第2道表示UVB控制組NER相關蛋白質的表現量,第3道表示實驗組NER相關蛋白質的表現量,其中實施例係於UVB照 射前與50 μM之牡丹皮苷D反應4小時,且於10 J/m2 之UVB照射後再與相同濃度之牡丹皮苷D反應8小時。Please refer to FIG. 10B, which shows a Western blot analysis of the protein expression of the nucleotide excision repair system (NER) of the HaCaT cell line with or without UVB irradiation using the peony saponin D of Example 1. Wherein, the first track represents the expression amount of the NER-related protein in the control group, the second track represents the expression amount of the NER-related protein in the UVB control group, and the third track represents the expression amount of the NER-related protein in the experimental group, wherein the embodiment is before the UVB irradiation It was reacted with 50 μM of pepiside D for 4 hours, and then reacted with the same concentration of peponin D for 8 hours after UVB irradiation at 10 J/m 2 .

由第10B圖之結果可知,相較於UVB控制組,實驗組之HaCaT細胞株在照射UVB前先與50 μM之牡丹皮苷D反應4小時、且在照射UVB後又與50 μM之牡丹皮苷D反應8小時後,可提升XPC、XPA、RPA、ERCC1、XPF、XPG及PCNA之表現量。From the results of Fig. 10B, it was found that the HaCaT cell line of the experimental group was reacted with 50 μM of puerarin D for 4 hours before irradiation with UVB, and with 50 μM of peony bark after UVB irradiation, compared with the UVB control group. After 8 hours of reaction with glycoside D, the expression levels of XPC, XPA, RPA, ERCC1, XPF, XPG and PCNA were increased.

(3)評估NER系統之相關蛋白質表現(II)(3) Assessment of related protein expression in the NER system (II)

上述各組(實驗組為照射50 J/m2 之UVB後再與相同濃度之牡丹皮苷D反應4小時)達反應時間後,分別收集上清液至15 mL離心管,再利用胰蛋白酶(trypsin,1×)取下細胞,經離心移除上清液後,加入500 μL之4%三聚甲醛(paraformaldehyde)於4℃反應1小時固定細胞並分析相關蛋白質表現。接著,加入5 μL之10% Triton X-100於4℃作用5分鐘後,進行離心去除上清液,加入如實施例二之第4表所示的一級抗體於4℃反應24小時。然後,加入FITC二級抗體(1:500)避光於室溫下反應3小時。隨後,將細胞液移至FACS專用的試管中,使用流式細胞分析儀,經由雷射光激發產生之綠色波長螢光(FL1 LOG)分析10000顆細胞,配合Winmdi電腦軟體來分析經化合物作用後,各種蛋白之螢光表現量並進行定量,其結果如第10C圖之所示。After the reaction time was reached in each of the above groups (the experimental group was irradiated with 50 J/m 2 of UVB and then reacted with the same concentration of pepiside D for 4 hours), the supernatant was separately collected into a 15 mL centrifuge tube, and trypsin was used again. Trypsin, 1×) Remove the cells, remove the supernatant by centrifugation, add 500 μL of 4% paraformaldehyde at 4 ° C for 1 hour to fix the cells and analyze the protein expression. Subsequently, 5 μL of 10% Triton X-100 was added thereto for 5 minutes at 4° C., and the supernatant was removed by centrifugation, and the primary antibody shown in the fourth table of Example 2 was added and reacted at 4° C. for 24 hours. Then, FITC secondary antibody (1:500) was added to avoid light and react at room temperature for 3 hours. Subsequently, the cell liquid was transferred to a FACS-dedicated test tube, and 10,000 cells were analyzed by a green wavelength fluorescence (FL1 LOG) generated by laser light excitation using a flow cytometer, and analyzed by the Winmdi computer software after the action of the compound. The amount of fluorescent expression of various proteins was quantified, and the results are shown in Fig. 10C.

請參閱第10C圖,其係顯示根據本發明數個實施例之利用流式細胞分析儀實施例一之牡丹皮苷D對於經或未經UVB照射之HaCaT細胞株的核苷酸切除修復系統(NER)之 相關蛋白表現的三維曲線圖,其中x軸代表螢光強度,y軸代表不同組別,z軸代表細胞數。y軸由近到遠分別為第1道至第5道,其中第1道表示陰性控制組(未經UVB照射之HaCaT細胞株)NER相關蛋白質的表現量,第2道表示控制組NER相關蛋白質的表現量,第3道表示UVB控制組NER相關蛋白質的表現量,第4道表示實驗組I(與50 μM之牡丹皮苷D反應)NER相關蛋白質的表現量,第5道表示實驗組II(與100 μM之牡丹皮苷D反應)NER相關蛋白質的表現量。Please refer to FIG. 10C, which shows a nucleotide excision repair system for HaCaT cell line with or without UVB irradiation using the flow cytometry Example 1 according to several embodiments of the present invention. NER) A three-dimensional graph of the expression of related proteins, where the x-axis represents the fluorescence intensity, the y-axis represents the different groups, and the z-axis represents the number of cells. The y-axis is from the first to the fifth, respectively, from the first to the fifth, wherein the first lane represents the expression of the NER-related protein in the negative control group (HaCaT cell line not irradiated with UVB), and the second lane represents the NER-related protein in the control group. The performance of the third lane indicates the expression of NER-related protein in the UVB control group, and the fourth lane indicates the performance of the NER-related protein in the experimental group I (reacted with 50 μM of peponin D), and the fifth lane indicates the experimental group II. (Reaction with 100 μM of puerarin D) The amount of NER-related protein.

由第10C圖可知,相較於控制組,UVB控制組於UVB(50 J/m2 )作用4小時後,其XPC、XPA、RPA、ERCC1、XPF、XPG及PCNA之表現降低。然而,實驗組之蛋白質表現卻隨著牡丹皮苷D反應濃度增加而明顯提升,證實實施例一之牡丹皮苷D可藉由提升NER相關蛋白之表現量,修復經紫外線照射後HaCaT細胞DNA之受損處。As can be seen from Fig. 10C, the performance of XPC, XPA, RPA, ERCC1, XPF, XPG and PCNA was decreased in the UVB control group after UVB (50 J/m 2 ) for 4 hours compared with the control group. However, the protein performance of the experimental group increased significantly with the increase of the reaction concentration of pepiside D. It was confirmed that the peony saponin D of Example 1 can repair the DNA of HaCaT cells after ultraviolet irradiation by increasing the expression of NER-related protein. Damaged place.

上述結果顯示實施例一之牡丹皮苷D可提升NER相關基因之DNA與蛋白質合成,進而促進細胞修復。The above results show that the peony saponin D of the first embodiment can enhance the DNA and protein synthesis of the NER-related gene, thereby promoting cell repair.

實施例六:評估牡丹皮苷D修復活體皮膚細胞之能力Example 6: Evaluation of the ability of pepiside D to repair living skin cells

此實施例係利用實施例一之牡丹皮苷D製備成凝膠以塗抹於活體皮膚,進一步評估其對於經UVB照射後的皮膚細胞之修復能力。This example was prepared by using the peony saponin D of Example 1 to be applied to a living skin to further evaluate its ability to repair skin cells after UVB irradiation.

首先,製備牡丹皮苷D凝膠,其係將實施例一之牡丹皮苷D配置為100 μM之濃度,各取10 μL加入於各自欲分散之1 mL生理食鹽水中,秤取2 g之羥乙基纖維素 (hydroxyethyl cellulose;HEC)凝膠加入並使其完全溶解,利用封口蠟膜(parafilm)封口避光,經24小時使膠體增稠凝集,以製得牡丹皮苷D凝膠(含2%之HEC與20 μg/mL之牡丹皮苷D)備用。First, a pebbina D gel was prepared by disposing the peony saponin D of Example 1 at a concentration of 100 μM, and each 10 μL was added to 1 mL of physiological saline to be dispersed, and 2 g of hydroxyl was weighed. Ethyl cellulose The (hydroxyethyl cellulose; HEC) gel was added and completely dissolved, and sealed with a parafilm seal to protect the light. The colloid was thickened and agglomerated over 24 hours to prepare a peony saponin D gel (containing 2% HEC). With 20 μg/mL of peponin D) spare.

同時,製備安慰劑,其係將2 g之HEC凝膠溶解於1 mL之生理食鹽水(pH值調整為6.47),利用封口蠟膜封口,經24小時使膠體增稠凝集,以製得安慰劑(含2%之HEC)備用。At the same time, placebo was prepared by dissolving 2 g of HEC gel in 1 mL of physiological saline (pH adjusted to 6.47), sealing with a sealing wax film, and thickening and aggregating the colloid over 24 hours to make a comfort. The agent (containing 2% HEC) is ready for use.

另外,將30隻C57BL/6JNarl品系5週大之公鼠(購自國科會動物實驗中心),以每5隻為一籠,飼養於具空調恆溫之動物飼養房中,其中飼養溫度保持在21±2℃、溼度保持在50%至60%並維持12小時切換之光暗循環。飼養期間不限制飼料及水的供應,其餘飼養條件均依循國家衛生研究院公告的相關實驗動物管理指南進行。待小鼠適應實驗環境一週後進行實驗(6週大),所有組別實驗過程皆在白天亮燈情況下進行。進行實驗前,先將小鼠背部脫毛放置24小時,每隻小鼠秤量體重後,進行腹腔麻醉注射(1 g/10 μl),將30隻小鼠依下述各組別進行處理。In addition, 30 C57BL/6JNarl strains of 5-week-old male rats (purchased from the National Animal Research Center of the National Science Association) were housed in a cage with 5 air conditioners in an air-conditioned animal house, in which the feeding temperature was maintained. 21 ± 2 ° C, humidity maintained at 50% to 60% and maintained a 12-hour switching light dark cycle. The feed and water supply are not restricted during the feeding period, and the remaining feeding conditions are carried out in accordance with the relevant experimental animal management guidelines announced by the National Institutes of Health. The mice were subjected to an experiment (6 weeks old) after one week of adaptation to the experimental environment, and all the experimental procedures were performed during daylighting. Before the experiment, the mice were depilated for 24 hours, and each mouse was weighed and administered with abdominal anesthesia (1 g/10 μl), and 30 mice were treated according to the following groups.

控制組係隨機取5隻小鼠,以皮膚色差計測量記錄每隻小鼠L、a、b值,不進行任何UVB照射及藥物處理,並於0、2、4、6、8小時之時間點,以色差計各別時間點測定L、a、b值,並同時進行皮膚組織之鑽孔切片(punch)。取下之皮膚組織的表皮層沾取紅藥水作記號,浸泡於4%三聚甲醛中儲存於4℃。Five mice were randomly selected from the control group, and the L, a, and b values of each mouse were recorded by skin colorimeter, without any UVB irradiation and drug treatment, and at 0, 2, 4, 6, and 8 hours. Point, the L, a, b values were measured at different time points of the color difference meter, and the punching of the skin tissue was simultaneously performed. The skin layer of the removed skin tissue was stained with red medicinal water and immersed in 4% paraformaldehyde and stored at 4 °C.

安慰劑控制組係隨機取5隻小鼠,以皮膚色差計測量 記錄每隻小鼠L、a、b值,每隻塗抹0.05 g的安慰劑但不進行任何UVB照射,並於0、2、4、6、8小時之時間點,以色差計測定L、a、b值,並同時進行皮膚組織之鑽孔切片(punch)。取下之皮膚組織的表皮層沾取紅藥水作記號,浸泡於4%三聚甲醛中儲存於4℃。5 mice were randomly selected from the placebo control group and measured with a skin colorimeter. The L, a, and b values of each mouse were recorded, and 0.05 g of each placebo was applied without any UVB irradiation, and L, a was measured by a color difference meter at 0, 2, 4, 6, and 8 hours. , b value, and simultaneously punching the skin tissue. The skin layer of the removed skin tissue was stained with red medicinal water and immersed in 4% paraformaldehyde and stored at 4 °C.

塗抹安慰劑之UVB控制組係隨機取5隻小鼠,以皮膚色差計測量記錄每隻小鼠L、a、b值,經脫毛後每隻小鼠於照射部位,每隻塗抹0.05 g的安慰劑作用4小時,進行UVB(2000 J/m2 )照射後,使用皮膚色差計測量記錄每隻小鼠L、a、b值。然後,於每隻小鼠於照射部位再塗抹0.05 g的安慰劑,各別測定與紀錄0、2、4、6、8小時之L、a、b值。隨後,於照射部位進行皮膚組織之鑽孔切片。取下之皮膚組織的表皮層沾取紅藥水作記號,浸泡於4%三聚甲醛中儲存於4℃。Five mice were randomly selected from the placebo-treated UVB control group. The L, a, and b values of each mouse were recorded by skin colorimeter. After depilation, each mouse was given a 0.05 g consolation at each irradiation site. The agent was allowed to act for 4 hours, and after UVB (2000 J/m 2 ) irradiation, the L, a, and b values of each mouse were recorded using a skin color difference meter. Then, 0.05 g of placebo was applied to each of the mice at the irradiation site, and the L, a, and b values were recorded and recorded for 0, 2, 4, 6, and 8 hours, respectively. Subsequently, a drilled section of the skin tissue is performed at the irradiation site. The skin layer of the removed skin tissue was stained with red medicinal water and immersed in 4% paraformaldehyde and stored at 4 °C.

實驗組係隨機取15隻小鼠,以皮膚色差計測量記錄每隻小鼠L、a、b值,隨機分配塗抹化合物組各5隻實驗小鼠,經脫毛後每隻小鼠於照射部位,每隻塗抹0.05 g的牡丹皮苷D凝膠,反應4小時。然後,進行UVB(2000 J/m2 )照射,以皮膚色差計測量記錄每隻小鼠於0小時、2小時、4小時、6小時、8小時之L、a、b值,並於各小鼠之照射部位再次塗抹0.05 g的牡丹皮苷D凝膠。之後,以皮膚色差計測量記錄於0小時、2小時、4小時、6小時、8小時之L、a、b值。隨後,於照射部位進行皮膚組織之鑽孔切片。取下之皮膚組織的表皮層沾取紅藥水作記號,浸泡於10%中性福馬林溶液(neutral formalin solution)中儲存於 4℃。In the experimental group, 15 mice were randomly selected, and the L, a, and b values of each mouse were recorded by skin color difference meter. Five experimental mice in each group of the smearing compound were randomly distributed. After depilation, each mouse was irradiated. Each of the 0.05 g of quercetin D gel was applied and reacted for 4 hours. Then, UVB (2000 J/m 2 ) irradiation was performed, and L, a, and b values of each mouse at 0 hours, 2 hours, 4 hours, 6 hours, and 8 hours were recorded and measured by a skin color difference meter, and each small A 0.05 g paeonin D gel was applied again to the irradiated area of the mouse. Thereafter, L, a, and b values recorded at 0 hours, 2 hours, 4 hours, 6 hours, and 8 hours were measured with a skin color difference meter. Subsequently, a drilled section of the skin tissue is performed at the irradiation site. The epidermis layer of the removed skin tissue was stained with red medicinal water and immersed in a 10% neutral formalin solution and stored at 4 °C.

前述浸泡於4%三聚甲醛以及10%中性福馬林溶液中的皮膚組織,隨後進行石蠟包埋,使液態石蠟逐漸取代組織中的水分。之後,將前述包埋盒於4℃約10分鐘使石蠟凝集,再放置於冷凍櫃增加石蠟硬度,以進行石蠟組織切片。所得之石蠟組織切片進一步利用蘇木紫-伊紅(hematoxylin-eosin;H&E)染色,藉此觀察細胞組織的形態結構是否產生變化,其結果如第11A圖之所示。上述之石蠟包埋、組織切片、H&E染色等應為本發明所屬技術領域中具有通常知識者所熟知,此處不再贅述。The aforementioned skin tissue soaked in 4% paraformaldehyde and 10% neutral formalin solution is subsequently paraffin-embedded to gradually replace the water in the tissue with liquid paraffin. Thereafter, the embedded cassette was agglutinated at 4 ° C for about 10 minutes, and then placed in a freezer to increase the paraffin hardness to perform paraffin tissue sectioning. The obtained paraffin tissue sections were further stained with hematoxylin-eosin (H&E) to observe whether or not the morphological structure of the cell tissues was changed, and the results are shown in Fig. 11A. The paraffin embedding, tissue sectioning, H&E staining and the like described above are well known to those of ordinary skill in the art to which the present invention pertains, and are not described herein.

另外,上述組織切片可進一步進行免疫組織化學染色(IHC)分析,其係利用螢光素異硫氰酸鹽(fluorescein isothiocyanate;FITC)標定之抗體進行原位染色,以專一性偵測組織切片中之NER相關蛋白並予以定位。簡言之,上述石蠟組織切片經脫蠟、水化後,浸泡於3% H2 O2 於4℃作用20分鐘,再以PBS清洗後,浸泡於檸檬酸緩衝溶液中,利用微波爐以4 W加熱3分鐘後,隨即更換冷的檸檬酸緩衝溶液並於4℃冷卻15分鐘,再利用微波爐以4 W加熱2分鐘。前述組織切片利用1×PBS清洗5分鐘後,加入阻隔緩衝液(blocking buffer)反應30分鐘,以填補組織間隙。然後,於組織切片滴上如第4表所示之一級抗體(1:100),於室溫處理2小時後,依序以PBS清洗組織兩次,再浸泡於PBST處理10分鐘,最後以清水清洗30分鐘。之後,於組織切片滴上二級抗體(1:500),避光於室溫下反應2小時後,依序以PBS清組織胞兩次,再浸泡於PBST 處理30分鐘。而後,於顯微鏡下觀察FITC螢光染色情形,再於組織滴上以1:250之比例的Hoechst 33342 staining solution(10 μg/ml)作用10分鐘,於顯微鏡下觀察組織細胞以及染色情形,其結果如第11B圖至第11I圖之「細胞核」所示。然後,利用PBS清洗細胞兩次,滴上封片膠蓋上蓋玻片,利用透明指甲油固定蓋玻片邊緣附著於載玻片上,於顯微鏡下進行螢光影像攝影分析,其結果如第11B圖至第11I圖之NER相關蛋白螢光染色所示。In addition, the above tissue sections can be further subjected to immunohistochemical staining (IHC) analysis, which is in situ stained with an antibody calibrated with fluorescein isothiocyanate (FITC) to specifically detect tissue sections. NER related proteins and localized. Briefly, the paraffin tissue sections were dewaxed and hydrated, soaked in 3% H 2 O 2 at 4 ° C for 20 minutes, washed with PBS, immersed in citric acid buffer solution, and microwaved at 4 W. After heating for 3 minutes, the cold citric acid buffer solution was replaced and cooled at 4 ° C for 15 minutes, and then heated in a microwave oven at 4 W for 2 minutes. The tissue sections were washed with 1×PBS for 5 minutes, and then reacted by adding a blocking buffer for 30 minutes to fill the interstitial space. Then, one-stage antibody (1:100) as shown in Table 4 was dropped on the tissue section, and after treatment at room temperature for 2 hours, the tissue was washed twice with PBS, then immersed in PBST for 10 minutes, and finally with water. Wash for 30 minutes. Thereafter, the secondary antibody (1:500) was dropped on the tissue section, and the reaction was allowed to stand at room temperature for 2 hours in the dark, and then the cells were washed twice with PBS, and then immersed in PBST for 30 minutes. Then, the FITC fluorescence staining was observed under a microscope, and Hoekst 33342 staining solution (10 μg/ml) at a ratio of 1:250 was applied to the tissue for 10 minutes, and the tissue cells and staining were observed under a microscope. As shown in the "nuclei" of Figures 11B to 11I. Then, the cells were washed twice with PBS, and the coverslips were covered with a sealing gel. The edges of the coverslips were fixed on the glass slides with transparent nail polish, and fluorescence imaging analysis was performed under a microscope. The result is shown in Fig. 11B. The fluorescent staining of the NER-related protein to Figure 11I is shown.

請參閱第11A圖至第11I圖,其係顯示根據本發明數個實施例之利用實施例一之牡丹皮苷D製備的凝膠塗抹於活體皮膚之組織化學染色(第11A圖)、細胞核染色(第11B圖至第11I圖)以及NER相關蛋白螢光染色(第11B圖至第11I圖)結果。由第11A圖之H&E stain之結果顯示,僅塗抹安慰劑之UVB控制組的表皮層稍顯增厚,但利用牡丹皮苷D凝膠塗抹之實驗組的組織較完整。其次,由第11B圖之細胞核染色(BrdU)結果顯示,BrdU表現量隨著牡丹皮萃取物凝膠之反應時間增加而增加。再著,由第11C圖至第11I圖之結果顯示,NER相關蛋白經化合物(1)、(2)作用後XPC、XPA、RPA、ERCC1、XPF、XPG及PCNA等NER相關蛋白之表現量隨著牡丹皮苷D凝膠之反應時間增加而增加,證實實施例一之牡丹皮苷D可藉由提升NER相關蛋白之表現量,修復經紫外線照射後活體皮膚細胞DNA之受損處。Please refer to FIGS. 11A to 11I, which show histochemical staining (Fig. 11A) and nuclear staining of a gel prepared by using the peony saponin D of Example 1 according to several embodiments of the present invention. (Fig. 11B to Fig. 11I) and NER-related protein fluorescence staining (Fig. 11B to Fig. 11I) results. From the results of the H&E stain of Fig. 11A, the epidermal layer of the UVB control group applied only with placebo was slightly thickened, but the tissue of the experimental group coated with the peony D-gel was relatively complete. Secondly, the results of nuclear staining (BrdU) from Fig. 11B showed that the amount of BrdU expression increased as the reaction time of the peony bark extract gel increased. Furthermore, the results from Fig. 11C to Fig. 11I show that the expression of NER-related proteins such as XPC, XPA, RPA, ERCC1, XPF, XPG and PCNA after NER-related proteins are treated by compounds (1) and (2) The reaction time of the paeonin D gel increased and it was confirmed that the peony saponin D of Example 1 can repair the damage of the DNA of the living skin cells after ultraviolet irradiation by increasing the expression of the NER-related protein.

實施例七:評估牡丹皮萃取物保護DNA抗氧化之能力Example 7: Assessing the ability of peony bark extract to protect DNA from oxidation 1.建立H1. Establish H 22 OO 22 與UVB處理的較適劑量Suitable dose with UVB treatment

皮膚細胞經由外界紫外線輻射照射或進行生理代謝均會引起氧化性壓力,造成DNA損傷。此實施例係利用不同濃度之H2 O2 及/或不同能量之UVB照射下,經由光解作用後形成之羥基自由基,攻擊質體DNA,藉此模擬自由基對DNA的傷害,進一步評估實施例一之牡丹皮苷D對於保護DNA抗氧化之能力。Skin cells that are exposed to ultraviolet radiation or physiological metabolism can cause oxidative stress and cause DNA damage. This embodiment uses different concentrations of H 2 O 2 and/or UVB irradiation of different energies to attack the plastid DNA via photodegradation of hydroxyl radicals, thereby simulating the damage of DNA by free radicals. The ability of pepiside D of Example 1 to protect DNA against oxidation.

首先,取pUC119質體DNA(0.5 μg/μL;Takara,Japan)與DNA分子量標準標記(DNA MW standard marker;經N-Hind III切割,以下簡稱λHind III標記;0.5 μg/μL;Takara,Japan),二者分別利用8倍體積的PBS稀釋後,依下述各組別進行處理。First, pUC119 plastid DNA (0.5 μg/μL; Takara, Japan) and DNA molecular weight standard marker (DNA MW standard marker; N-Hind III cleavage, hereinafter referred to as λHind III label; 0.5 μg/μL; Takara, Japan) The two were diluted with 8 volumes of PBS and treated according to the following groups.

控制組係分別取2 μL經PBS稀釋後之pUC119質體DNA(0.056 μg/μL)或2 μL經PBS稀釋後之λHind III標記(0.056 μg/μL),分別加入8 μL之PBS後,二者利用瓊脂凝膠進行核酸電泳分析。2 μL of pUC119 plastid DNA (0.056 μg/μL) diluted with PBS or 2 μL of λHind III labeled (0.056 μg/μL) diluted with PBS were added to the control group, respectively, and 8 μL of PBS was added. Nucleic acid electrophoresis analysis was performed using an agar gel.

對照組係取2 μL之上述利用PBS稀釋後之pUC119質體DNA(0.056 μg/μL),加入6.5 μL之ddH2 O、1 μL之限制酶反應溶液(H buffer)以及0.5μL之限制酶EcoRI(15 unit/μL;Takara,Japan),於37℃作用1小時後,利用瓊脂凝膠進行核酸電泳分析。In the control group, 2 μL of the above pUC119 plastid DNA (0.056 μg/μL) diluted with PBS was added, and 6.5 μL of ddH 2 O, 1 μL of restriction enzyme reaction solution (H buffer) and 0.5 μL of restriction enzyme EcoRI were added. (15 unit/μL; Takara, Japan), after 1 hour of action at 37 ° C, nucleic acid electrophoresis analysis was performed using an agar gel.

H2 O2 與UVB處理組係將上述利用PBS稀釋後之pUC119質體DNA(0.056 μg/μL)或λHind III標記(0.056 μg/μL),各別取2 μL加入3 μL之PBS和5 μL之H2 O2 (濃度分別為5 mM與20 mM)。接著,pUC119 DNA Plasmid 照射200 J/m2 之UVB,而λHind III標記則照射3500 J/m2 、4000 J/m2 之UVB後,二者利用瓊脂凝膠進行核酸電泳分析。The H 2 O 2 and UVB treatment groups were treated with pUC119 plastid DNA (0.056 μg/μL) or λHind III (0.056 μg/μL) diluted with PBS, and 2 μL of each was added to 3 μL of PBS and 5 μL. H 2 O 2 (concentrations of 5 mM and 20 mM, respectively). Next, the pUC119 DNA Plasmid was irradiated with 200 J/m 2 of UVB, and the λ Hind III label was irradiated with 3500 J/m 2 and 4000 J/m 2 of UVB, and the two were subjected to nucleic acid electrophoresis analysis using an agar gel.

上述核酸電泳係使用濃度0.8%之瓊脂凝膠進行電泳30分鐘。然後,利用影像擷取分析系統拍下電泳膠片並進行影像分析,以控制組之DNA色帶濃度為100%,分別計算出各組之超螺旋(supercoil;SC)型DNA、開環(open circular;OC)型DNA以及線型(linear;LN)DNA之百分比(%)。The above nucleic acid electrophoresis was carried out by electrophoresis using a 0.8% agar gel for 30 minutes. Then, using the image capture analysis system to take the electrophoretic film and perform image analysis, the DNA ribbon concentration of the control group is 100%, and the supercoil (SC) type DNA and open loop (open circular) of each group are respectively calculated. OC) type DNA and percentage (%) of linear (LN) DNA.

一般而言,pUC119質體DNA主要原為超螺旋(supercoil;SC)結構(圖未繪示),經上述EcoRI 限制內切酶處理後,可將pUC119質體DNA剪切成線型(LN)結構(圖未繪示)。當pUC119質體DNA暴露於5 mM之H2 O2 且UVB照射能量達200 J/m2 時,亦可將質體DNA完全剪切成線型(LN)結構(圖未繪示)。隨著H2 O2 濃度愈高,將pUC119質體DNA完全剪切成線型(LN)結構所需的UVB照射能量就愈低。當pUC119質體DNA暴露於40 mM之H2 O2 時,將pUC119質體DNA完全剪切成線型(LN)結構所需的UVB照射能量,與暴露於20 mM之H2 O2 時所需的UVB照射能量十分相近(圖未繪示)。In general, pUC119 plastid DNA is mainly supercoil (SC) structure (not shown). After treatment with the above EcoRI restriction endonuclease, pUC119 plastid DNA can be cut into linear (LN) structure. (The figure is not shown). When the pUC119 plastid DNA is exposed to 5 mM H 2 O 2 and the UVB irradiation energy is 200 J/m 2 , the plastid DNA can also be completely cut into a linear (LN) structure (not shown). The higher the concentration of H 2 O 2 , the lower the UVB irradiation energy required to completely shear the pUC119 plastid DNA into a linear (LN) structure. When the pUC119 plastid DNA is exposed to 40 mM H 2 O 2 , the UVB irradiation energy required to completely cleave pUC119 plastid DNA into a linear (LN) structure is required for exposure to 20 mM H 2 O 2 The UVB irradiation energy is very similar (not shown).

DNA線型片段亦可獲得類似的結果,以λHind III標記為例,其包括多種不同分子量之DNA線型片段,隨著UVB照射能量的增加,DNA片段之損傷就越嚴重。當λHind III標記暴露於5 mM之H2 O2 且UVB照射能量達3500 J/m2 時,可將λHind III DNA剪切成較碎小的片段(圖未繪示)。 隨著H2 O2 濃度愈高,將λHind III DNA剪切成較碎小片段所需的UVB照射能量就愈低(圖未繪示)。Similar results were obtained for DNA linear fragments, exemplified by the λHind III label, which includes DNA linear fragments of various molecular weights, and the damage of the DNA fragments is more severe as the energy of UVB irradiation increases. When the λHind III label is exposed to 5 mM H 2 O 2 and the UVB irradiation energy reaches 3500 J/m 2 , the λHind III DNA can be cut into smaller fragments (not shown). As the H 2 O 2 concentration is higher, the UVB irradiation energy required to shear the λHind III DNA into smaller fragments is lower (not shown).

根據上述結果,以下係選擇將pUC119質體DNA與λHind III DNA分別暴露於5 mM與20 mM之H2 O2 時,並分別利用照射劑量200 J/m2 以及3500 J/m2 之UVB進行照射,藉此評估實施例一之牡丹皮萃取物是否可保護DNA抗氧化且避免DNA損傷。Based on the above results, the following selection was performed to expose pUC119 plastid DNA and λHind III DNA to 5 mM and 20 mM H 2 O 2 , respectively, and to use UVB at an irradiation dose of 200 J/m 2 and 3500 J/m 2 , respectively. Irradiation, thereby evaluating whether the peony bark extract of Example 1 can protect DNA from oxidation and avoid DNA damage.

2.評估牡丹皮萃取物保護DNA抗氧化且避免DNA損傷的能力2. Evaluate the ability of peony bark extract to protect DNA against oxidation and avoid DNA damage

此實施例先於pUC119質體DNA或λHind III DNA中加入50 μM或100 μM實施例一之牡丹苷D,再藉由UVB照射與H2 O2 誘導,將pUC119質體DNA或λHind III DNA分別暴露於5 mM與20 mM之H2 O2 ,再分別利用照射劑量200 J/m2 以及3500 J/m2 之UVB進行照射,然後利用上述評估方法確認牡丹皮苷D是否可保護DNA抗氧化且避免DNA損傷。此處評估的控制組、對照組、H2 O2 與UVB處理組、H2 O2 與UVB處理方法與核酸電泳分析與前述相同,此處不作贅言。In this example, 50 μM or 100 μM of peony D of Example 1 was added to pUC119 plastid DNA or λHind III DNA, and then induced by UVB irradiation and H 2 O 2 to separate pUC119 plastid DNA or λHind III DNA. Exposure to 5 mM and 20 mM H 2 O 2 , and irradiation with UVB at an irradiation dose of 200 J/m 2 and 3500 J/m 2 , respectively, and then using the above evaluation method to confirm whether peponin D can protect DNA against oxidation And avoid DNA damage. The control group, the control group, the H 2 O 2 and UVB treatment groups evaluated here, the H 2 O 2 and UVB treatment methods, and the nucleic acid electrophoresis analysis were the same as described above, and no rumors are made here.

至於實驗組I係取2 μL上述利用PBS稀釋後之pUC119質體DNA(0.056 μg/μL),加入3 μL實施例一之牡丹皮苷D(濃度50 μM或100 μM),再各別和5 μL之H2 O2 (5 mM或20 mM)混合後,照射UVB(200 J/m2 ),再利用瓊脂凝膠進行核酸電泳分析。For the experimental group I, take 2 μL of the above pUC119 plastid DNA diluted with PBS (0.056 μg/μL), and add 3 μL of the peony saponin D of Example 1 (concentration 50 μM or 100 μM), and then 5 and 5 After mixing μL of H 2 O 2 (5 mM or 20 mM), UVB (200 J/m 2 ) was irradiated, and nucleic acid electrophoresis analysis was performed using an agar gel.

實驗組II則取2 μL上述經PBS稀釋後之λHind III標記(0.056 μg/μL),加入3 μL實施例一之牡丹皮苷D(濃度 50 μM或100 μM),再各別和5 μL之H2 O2 (5 mM或20 mM)混合後,照射UVB(200 J/m2 ),再利用瓊脂凝膠進行核酸電泳分析。上述結果如第12A圖至第12B圖所示。In the experimental group II, 2 μL of the above-mentioned λHind III labeled with PBS (0.056 μg/μL) was added, and 3 μL of the peony saponin D of Example 1 (concentration of 50 μM or 100 μM) was added, and then each and 5 μL. After mixing with H 2 O 2 (5 mM or 20 mM), UVB (200 J/m 2 ) was irradiated, and nucleic acid electrophoresis analysis was performed using an agar gel. The above results are shown in Figures 12A to 12B.

請參閱第12A圖至第12B圖,其係顯示利用實施例一之牡丹皮苷D對於保護DNA抗氧化之核酸電泳圖,其中第12A圖係顯示pUC119質體DNA經不同濃度之H2 O2 及/或不同能量之UVB處理後之核酸電泳圖,而第12B圖則顯示λHind III標記經不同濃度之H2 O2 及/或不同能量之UVB處理後之核酸電泳圖。Please refer to Fig. 12A to Fig. 12B, which are diagrams showing the electrophoresis of nucleic acid against the oxidation of DNA by using the peony saponin D of the first embodiment, wherein the 12A map shows that the pUC119 plastid DNA is subjected to different concentrations of H 2 O 2 . And/or nucleic acid electrophoresis patterns after UVB treatment of different energies, and Fig. 12B shows nucleic acid electrophoresis patterns of λHind III labeling treated with different concentrations of H 2 O 2 and/or UVB of different energies.

由第12A圖至第12B之核酸電泳圖的結果顯示,pUC119質體DNA主要原為超螺旋(SC)結構(如第12A圖之控制組所示),經EcoRI 限制內切酶處理後,可將pUC119質體DNA剪切成線型(LN)結構(如第12A圖之對照組所示)。當pUC119質體DNA先加入實施例一之牡丹皮苷D後,再暴露於5 mM或20 mM之H2 O2 且UVB照射能量達200 J/m2 時,50 μM或100 μM牡丹皮苷D可有效保護且避免大部分的質體DNA不被剪切成線型(LN)結構,如第12A圖之實驗組I的色帶所示。The results of the nucleic acid electrophoresis patterns from Fig. 12A to Fig. 12B show that the plastid DNA of pUC119 is mainly a supercoiled (SC) structure (as shown in the control group of Fig. 12A), and after treatment with EcoRI restriction endonuclease, The pUC119 plastid DNA was cut into a linear (LN) structure (as shown in the control group of Figure 12A). When pUC119 plastid DNA was first added to the peony saponin D of Example 1, and then exposed to 5 mM or 20 mM H 2 O 2 and UVB irradiation energy of 200 J/m 2 , 50 μM or 100 μM peony saponin D is effective in protecting and avoiding that most of the plastid DNA is not sheared into a linear (LN) structure, as shown by the band of experimental group I in Figure 12A.

第12B圖亦可獲得類似的結果。由第12B圖之核酸電泳圖的結果顯示,當λHind III標記暴露於5 mM或20 mM之H2 O2 且UVB照射能量達3500 J/m2 時,可將λHind III DNA剪切成較碎小的片段,如第12B圖之實驗組II的色帶所示。當λHind III標記先加入實施例一之牡丹皮苷D後,再暴露於5 mM或20 mM之H2 O2 且UVB照射能量達3500 J/m2 時,50 μM或100 μM牡丹皮苷D可有效保護且避免 大部分的λHind III標記不被剪切成較碎小的片段,如第12B圖之實驗組II的色帶所示。Similar results can be obtained with Figure 12B. The results of the electrophoresis pattern of the nucleic acid shown in Fig. 12B show that when the λHind III label is exposed to 5 mM or 20 mM H 2 O 2 and the UVB irradiation energy reaches 3500 J/m 2 , the λHind III DNA can be cut into smaller pieces. Small fragments are shown in the ribbon of Experiment Group II in Figure 12B. When the λHind III label was added to the peony saponin D of Example 1, and then exposed to 5 mM or 20 mM H 2 O 2 and the UVB irradiation energy reached 3500 J/m 2 , 50 μM or 100 μM peponin D It is effective to protect and avoid most of the λHind III label from being cut into smaller fragments, as shown by the ribbon of Experiment Group II in Figure 12B.

綜合以上實施例結果,實施例一之牡丹皮苷D不僅具抑制黑色素生成、促使DNA複製及調控NER修復機制,更可有效預防及保護DNA避免因H2 O2 與UVB照射而引發損傷。Based on the results of the above examples, the peony saponin D of the first embodiment not only inhibits melanin production, promotes DNA replication, and regulates the NER repair mechanism, but also effectively prevents and protects DNA from damage caused by H 2 O 2 and UVB irradiation.

需補充的是,本發明雖以特定的製程條件、特定細胞株、特定分析方法或特定儀器為例示,說明本發明之牡丹皮萃取物及其製造方法之應用,惟本發明所屬技術領域中任何具有通常知識者可知,本發明並不限於此,在不脫離本發明之精神和範圍內,本發明之牡丹皮萃取物可使用其他製程條件、其他細胞株、其他分析方法或儀器進行。此外,本發明所得之牡丹皮苷D應用於化妝品組合物時,其形式可包括但不限於水劑、乳劑、膏劑、粉劑、美白劑、淡斑劑、袪斑劑或上述任意組合之化妝品。再者,本發明所得之牡丹皮苷D應用於食品添加物時,其形式可包括但不限於營養品或保健食品。It should be noted that the present invention is exemplified by specific process conditions, specific cell strains, specific analytical methods or specific instruments, and illustrates the application of the peony bark extract of the present invention and a method for producing the same, but any of the technical fields of the present invention. It is to be understood by those skilled in the art that the present invention is not limited thereto, and the peony peel extract of the present invention can be carried out using other process conditions, other cell strains, other analytical methods or instruments without departing from the spirit and scope of the present invention. Further, when the pepiside D obtained by the present invention is applied to a cosmetic composition, the form thereof may include, but is not limited to, a liquid, an emulsion, an ointment, a powder, a whitening agent, a spotting agent, a freckle agent, or a cosmetic of any combination thereof. Further, when the pepiside D obtained by the present invention is applied to a food additive, the form thereof may include, but is not limited to, a nutraceutical or a health food.

由上述本發明實施例可知,本發明之牡丹皮萃取物及其製造方法,其優點在於利用至少一分配萃取步驟以及至少一管柱分離步驟,可有效獲得單萜醣苷類化合物之牡丹皮苷D,以提供DNA修復、抑制黑色素生成以及抗氧化的生物活性。由於利用本發明之單萜醣苷類化合物之牡丹皮苷D兼具多種生物活性,故所得之牡丹皮苷D可應用於化妝品組合物及/或食品添加物。It can be seen from the above embodiments of the present invention that the peony bark extract of the present invention and the method for producing the same have the advantages that the peony glucoside D of the monoterpene glycoside compound can be effectively obtained by using at least one partitioning extraction step and at least one column separation step. To provide DNA repair, inhibition of melanin production, and antioxidant biological activity. Since the quercetin D of the monoterpene glycoside compound of the present invention has various biological activities, the obtained pepiside D can be applied to a cosmetic composition and/or a food additive.

雖然本發明已以數個實施例揭露如上,然其並非用以 限定本發明,在本發明所屬技術領域中任何具有通常知識者,在不脫離本發明之精神和範圍內,當可作各種之更動與潤飾,因此本發明之保護範圍當視後附之申請專利範圍所界定者為準。Although the invention has been disclosed above in several embodiments, it is not intended to The invention is defined by the general knowledge of the present invention, and various modifications and refinements can be made without departing from the spirit and scope of the invention. The scope is defined.

100‧‧‧方法100‧‧‧ method

101‧‧‧提供牡丹皮材料之步驟101‧‧‧Procedures for providing peony skin material

103‧‧‧利用第一有機溶液對牡丹皮材料進行粗萃取步驟,以獲得粗萃物之步驟103‧‧‧Steps of crude extraction of the peony bark material using the first organic solution to obtain the crude extract

105‧‧‧利用第二有機溶液對粗萃物進行第一分配萃取步驟,以獲得第一萃取物之步驟105‧‧‧Step of performing a first partition extraction step on the crude extract using the second organic solution to obtain the first extract

107‧‧‧利用第三有機水溶液對第一萃取物進行第二分配萃取步驟,以獲得第三有機相之步驟107‧‧‧Step of performing a second partition extraction step on the first extract with a third organic aqueous solution to obtain a third organic phase

109‧‧‧利用第四有機溶液對水相進行第三分配萃取步驟,以獲得第四有機相之步驟109‧‧‧Step of using the fourth organic solution to carry out the third partition extraction step of the aqueous phase to obtain the fourth organic phase

111‧‧‧對第三有機相進行第一矽膠管柱層析步驟,以獲得第一溶離液與殘留物之步驟111‧‧‧Step of performing a first xylene column chromatography step on the third organic phase to obtain the first eluent and residue

113‧‧‧合併殘留物與第四有機相,進行第二矽膠管柱層析步驟,以獲得含有牡丹皮萃取物之第二溶離液之步驟113‧‧‧ Combining the residue with the fourth organic phase, performing a second xylene column chromatography step to obtain a second eluate containing the peony bark extract

為讓本發明之上述和其他目的、特徵、優點與實施例能更明顯易懂,所附圖式之詳細說明如下:第1圖係繪示習知技術之牡丹皮萃取物之製造方法流程圖。The above and other objects, features, advantages and embodiments of the present invention will become more <RTIgt; .

第2A圖至第2F圖係顯示根據本發明數個實施例之HaCaT細胞株、B16細胞株、BNL CL.2細胞株以及Hs68細胞株與實施例一之牡丹皮苷D或維生素C作用72小時後的細胞存活率曲線圖。2A to 2F show the HaCaT cell line, the B16 cell line, the BNL CL.2 cell line, and the Hs68 cell line according to several embodiments of the present invention, and the peony saponin D or vitamin C of Example 1 for 72 hours. Post-cell survival rate graph.

第3圖係繪示利用實施例一之牡丹皮苷D抑制蘑菇酪胺酸酶活性的直方圖。Figure 3 is a histogram showing inhibition of mushroom tyrosinase activity by the use of peony saponin D of Example 1.

第4A圖與第4B圖係分別繪示評估實施例一之牡丹皮苷D對於抑制細胞外黑色素含量(第4A圖)與細胞內黑色素含量(第4B圖)之相對比率的直方圖。Figures 4A and 4B are graphs showing the relative ratios of the peony saponin D for inhibiting extracellular melanin content (Fig. 4A) to intracellular melanin content (Fig. 4B), respectively.

第5A圖係顯示利用實施例一之牡丹皮苷D對於B16細胞株於黑色素生成時之相關基因表現的瓊脂膠體照片。Fig. 5A is a photograph showing the agar colloid of the gene expression of the B16 cell line in the case of melanin production using the peony saponin D of Example 1.

第5B圖係顯示利用實施例一之牡丹皮苷D對於B16細胞株於黑色素生成時之相關蛋白表現的西方墨點分析圖。Fig. 5B is a Western blot analysis showing the expression of related proteins of the B16 cell line in the case of melanin production using the peony saponin D of Example 1.

第5C圖係顯示利用實施例一之牡丹皮苷D對於B16 細胞株於黑色素生成時之相關蛋白表現的三維曲線圖。Figure 5C shows the use of the peony saponin D of Example 1 for B16 A three-dimensional graph of the expression of related proteins in cell lines during melanin production.

第6A圖與第6B圖係繪示利用實施例一之牡丹皮苷D對於經UVB照射後之HaCaT細胞株(第6A圖)以及Hs68細胞株(第6B圖)的細胞存活率曲線圖。Fig. 6A and Fig. 6B are graphs showing the cell viability of the HaCaT cell line (Fig. 6A) and the Hs68 cell line (Fig. 6B) after the UVB irradiation using the peony saponin D of Example 1.

第7A圖係顯示利用實施例一之牡丹皮苷D處理並經UVB照射後之HaCaT細胞株的彗星試驗照片。Fig. 7A is a photograph showing a comet assay of a HaCaT cell strain treated with the peony saponin D of Example 1 and irradiated with UVB.

第7B圖係繪示利用實施例一之牡丹皮苷D處理並經UVB照射後之HaCaT細胞株之DNA受損的細胞數直方圖第8圖係顯示利用實施例一之牡丹皮苷D對於經或未經UVB照射之HaCaT細胞株的細胞週期分佈圖。Fig. 7B is a histogram showing the number of cells damaged by the HaCaT cell line treated with the peony saponin D of Example 1 and irradiated with UVB. Fig. 8 shows the use of the peony saponin D of Example 1. Or cell cycle profile of HaCaT cell lines that were not irradiated with UVB.

第9A圖與第9B圖係分別顯示利用實施例一之牡丹皮苷D對於經或未經UVB照射之HaCaT細胞株(第9A圖)與Hs68細胞株(第9B圖)的BrdU螢光強度直方圖。Fig. 9A and Fig. 9B show the BrdU fluorescence intensity histogram of the HaCaT cell line (Fig. 9A) and the Hs68 cell line (Fig. 9B) with or without UVB irradiation, respectively, using the peony saponin D of Example 1. Figure.

第9C圖則顯示利用實施例一之牡丹皮苷D對於HaCaT細胞株經免疫螢光染色之細胞照片(放大倍率為200倍)。Fig. 9C shows a photograph of a cell which was immunofluorescently stained for HaCaT cell strain using the peony saponin D of Example 1 (magnification: 200 times).

第10A圖係顯示利用實施例一之牡丹皮苷D對於經或未經UVB照射之HaCaT細胞株的核苷酸切除修復系統(NER)之相關基因表現的直方圖。Figure 10A is a histogram showing the expression of related genes of the nucleotide excision repair system (NER) of the HaCaT cell line with or without UVB irradiation using the peony saponin D of Example 1.

第10B圖係顯示利用實施例一之牡丹皮苷D對於經或未經UVB照射之HaCaT細胞株的核苷酸切除修復系統(NER)之相關蛋白質表現的西方轉漬法分析圖。Figure 10B is a Western blot analysis showing the protein expression of the nucleotide excision repair system (NER) of the HaCaT cell line with or without UVB irradiation using the peony saponin D of Example 1.

第10C圖係顯示根據本發明數個實施例之利用流式細胞分析儀實施例一之牡丹皮苷D對於經或未經UVB照射之HaCaT細胞株的核苷酸切除修復系統(NER)之相關蛋白表現的三維曲線圖。Figure 10C shows the correlation of the nucleoside excision repair system (NER) of the HaCaT cell line with or without UVB irradiation using the flow cytometry Example 1 according to several embodiments of the present invention. A three-dimensional graph of protein expression.

第11A圖至第11I圖係分別顯示根據本發明數個實施例利用實施例一之牡丹皮苷D製備的凝膠塗抹於活體皮膚之組織化學染色(第11A圖)、細胞核染色以及NER相關蛋白螢光染色(第11B圖至第11I圖)結果。11A to 11I are respectively showing histochemical staining (Fig. 11A), nuclear staining, and NER-related protein of a gel prepared by using the peony saponin D of Example 1 according to several embodiments of the present invention. Fluorescent staining (Fig. 11B to Fig. 11I) results.

第12A圖與第12B圖係分別顯示根據本發明數個實施例之pUC119質體DNA(第12A圖)與λHind III標記(第12B圖)經不同濃度之H2 O2 及/或不同能量之UVB處理後之核酸電泳圖。Figures 12A and 12B show respectively different concentrations of H 2 O 2 and/or different energies of pUC119 plastid DNA (Fig. 12A) and λHind III label (Fig. 12B) according to several embodiments of the present invention. The nucleic acid electrophoresis pattern after UVB treatment.

<110> 嘉南藥理科技大學<110> Jianan University of Pharmacy and Technology

<120> 牡丹皮萃取物及其製造方法暨應用<120> Mudan peel extract, its manufacturing method and application

<130> 無<130> None

<160> 28<160> 28

<210> 1<210> 1

<211> 21<211> 21

<212> DNA<212> DNA

<213> 人工序列<213> Artificial sequence

<220> primer<220> primer

<223> PCR forward primer(MC1R F)<223> PCR forward primer ( MC1R F)

<400> 1 <400> 1

<210> 2<210> 2

<211> 23<211> 23

<212> DNA<212> DNA

<213> 人工序列<213> Artificial sequence

<220> primer<220> primer

<223> PCR reverse primer(MC1R R)<223> PCR reverse primer ( MC1R R)

<400> 2 <400> 2

<210> 3<210> 3

<211> 18<211> 18

<212> DNA<212> DNA

<213> 人工序列<213> Artificial sequence

<220> primer<220> primer

<223> PCR forward primer(MITF F)<223> PCR forward primer ( MITF F)

<400> 3 <400> 3

<210> 4<210> 4

<211> 22<211> 22

<212> DNA<212> DNA

<213> 人工序列<213> Artificial sequence

<220> primer<220> primer

<223> PCR reverse primer(MITF R)<223> PCR reverse primer ( MITF R)

<400> 4 <400> 4

<210> 5<210> 5

<211> 24<211> 24

<212> DNA<212> DNA

<213> 人工序列<213> Artificial sequence

<220> primer<220> primer

<223> PCR forward primer(Tyrosinase F)<223> PCR forward primer(Tyrosinase F)

<400> 5 <400> 5

<210> 6<210> 6

<211> 21<211> 21

<212> DNA<212> DNA

<213> 人工序列<213> Artificial sequence

<220> primer<220> primer

<223> PCR reverse primer(Tyrosinase R)<223> PCR reverse primer (Tyrosinase R)

<400> 6 <400> 6

<210> 7<210> 7

<211> 20<211> 20

<212> DNA<212> DNA

<213> 人工序列<213> Artificial sequence

<220> primer<220> primer

<223> PCR forward primer(TRP-1 F)<223> PCR forward primer( TRP-1 F)

<400> 7 <400> 7

<210> 8<210> 8

<211> 20<211> 20

<212> DNA<212> DNA

<213> 人工序列<213> Artificial sequence

<220> primer<220> primer

<223> PCR reverse primer(TRP-1 R)<223> PCR reverse primer ( TRP-1 R)

<400> 8 <400> 8

<210> 9<210> 9

<211> 20<211> 20

<212> DNA<212> DNA

<213> 人工序列<213> Artificial sequence

<220> primer<220> primer

<223> PCR reverse primer(TRP-2 F)<223> PCR reverse primer ( TRP-2 F)

<400> 9 <400> 9

<210> 10<210> 10

<211> 20<211> 20

<212> DNA<212> DNA

<213> 人工序列<213> Artificial sequence

<220> primer<220> primer

<223> PCR reverse primer(TRP-2 R)<223> PCR reverse primer ( TRP-2 R)

<400> 10 <400> 10

<210> 11<210> 11

<211> 20<211> 20

<212> DNA<212> DNA

<213> 人工序列<213> Artificial sequence

<220> primer<220> primer

<223> PCR forward primer(β-actin F)<223> PCR forward primer( β-actin F)

<400> 11 <400> 11

<210> 12<210> 12

<211> 17<211> 17

<212> DNA<212> DNA

<213> 人工序列<213> Artificial sequence

<220> primer<220> primer

<223> PCR reverse primer(β-actin R)<223> PCR reverse primer( β-actin R)

<400> 12 <400> 12

<210> 13<210> 13

<211> 17<211> 17

<212> DNA<212> DNA

<213> 人工序列<213> Artificial sequence

<220> primer<220> primer

<223> PCR forward primer(XPC F)<223> PCR forward primer ( XPC F)

<400> 13 <400> 13

<210> 14<210> 14

<211> 26<211> 26

<212> DNA<212> DNA

<213> 人工序列<213> Artificial sequence

<220> primer<220> primer

<223> PCR reverse primer(XPC R)<223> PCR reverse primer ( XPC R)

<400> 14 <400> 14

<210> 15<210> 15

<211> 20<211> 20

<212> DNA<212> DNA

<213> 人工序列<213> Artificial sequence

<220> primer<220> primer

<223> PCR forward primer(XPA F)<223> PCR forward primer ( XPA F)

<400> 15 <400> 15

<210> 16<210> 16

<211> 22<211> 22

<212> DNA<212> DNA

<213> 人工序列<213> Artificial sequence

<220> primer<220> primer

<223> PCR reverse primer(XPA R)<223> PCR reverse primer ( XPA R)

<400> 16 <400> 16

<210> 17<210> 17

<211> 20<211> 20

<212> DNA<212> DNA

<213> 人工序列<213> Artificial sequence

<220> primer<220> primer

<223> PCR forward primer(RPA F)<223> PCR forward primer ( RPA F)

<400> 17 <400> 17

<210> 18<210> 18

<211> 20<211> 20

<212> DNA<212> DNA

<213> 人工序列<213> Artificial sequence

<220> primer<220> primer

<223> PCR reverse primer(RPA R)<223> PCR reverse primer ( RPA R)

<400> 18 <400> 18

<210> 19<210> 19

<211> 19<211> 19

<212> DNA<212> DNA

<213> 人工序列<213> Artificial sequence

<220> primer<220> primer

<223> PCR forward primer (ERCC1 F)<223> PCR forward primer ( ERCC1 F)

<400> 19 <400> 19

<210> 20<210> 20

<211> 21<211> 21

<212> DNA<212> DNA

<213> 人工序列<213> Artificial sequence

<220> primer<220> primer

<223> PCR reverse primer(ERCC1 R)<223> PCR reverse primer( ERCC1 R)

<400> 20 <400> 20

<210> 21<210> 21

<211> 18<211> 18

<212> DNA<212> DNA

<213> 人工序列<213> Artificial sequence

<220> primer<220> primer

<223> PCR forward primer(XPF(ERCC4) F)<223> PCR forward primer( XPF(ERCC4) F)

<400> 21 <400> 21

<210> 22<210> 22

<211> 23<211> 23

<212> DNA<212> DNA

<213> 人工序列<213> Artificial sequence

<220> primer<220> primer

<223> PCR reverse primer(XPF(ERCC4) R)<223> PCR reverse primer (XPF(ERCC4) R)

<400> 22 <400> 22

<210> 23<210> 23

<211> 17<211> 17

<212> DNA<212> DNA

<213> 人工序列<213> Artificial sequence

<220> primer<220> primer

<223> PCR forward primer(XPG(ERCC5) F)<223> PCR forward primer( XPG(ERCC5) F)

<400> 23 <400> 23

<210> 24<210> 24

<211> 25<211> 25

<212> DNA<212> DNA

<213> 人工序列<213> Artificial sequence

<220> primer<220> primer

<223> PCR reverse primer(XPG(ERCC5) R)<223> PCR reverse primer ( XPG(ERCC5) R)

<400> 24 <400> 24

<210> 25<210> 25

<211> 24<211> 24

<212> DNA<212> DNA

<213> 人工序列<213> Artificial sequence

<220> primer<220> primer

<223> PCR forward primer(PCNA F)<223> PCR forward primer ( PCNA F)

<400> 25 <400> 25

<210> 26<210> 26

<211> 26<211> 26

<212> DNA<212> DNA

<213> 人工序列<213> Artificial sequence

<220> primer<220> primer

<223> PCR reverse primer(PCNA R)<223> PCR reverse primer ( PCNA R)

<400> 26 <400> 26

<210> 27<210> 27

<211> 20<211> 20

<212> DNA<212> DNA

<213> 人工序列<213> Artificial sequence

<220> primer<220> primer

<223> PCR forward primer(β-actin F)<223> PCR forward primer( β-actin F)

<400> 27 <400> 27

<210> 28<210> 28

<211> 17<211> 17

<212> DNA<212> DNA

<213> 人工序列<213> Artificial sequence

<220> primer<220> primer

<223> PCR reverse primer(β-actin R)<223> PCR reverse primer( β-actin R)

<400> 28 <400> 28

100‧‧‧方法100‧‧‧ method

101‧‧‧提供牡丹皮材料之步驟101‧‧‧Procedures for providing peony skin material

103‧‧‧利用第一有機溶液對牡丹皮材料進行粗萃取步驟,以獲得粗萃物之步驟103‧‧‧Steps of crude extraction of the peony bark material using the first organic solution to obtain the crude extract

105‧‧‧利用第二有機溶液對粗萃物進行第一分配萃取步驟,以獲得第一萃取物之步驟105‧‧‧Step of performing a first partition extraction step on the crude extract using the second organic solution to obtain the first extract

107‧‧‧利用第三有機水溶液對第一萃取物進行第二分配萃取步驟,以獲得第三有機相之步驟107‧‧‧Step of performing a second partition extraction step on the first extract with a third organic aqueous solution to obtain a third organic phase

109‧‧‧利用第四有機溶液對水相進行第三分配萃取步驟,以獲得第四有機相之步驟109‧‧‧Step of using the fourth organic solution to carry out the third partition extraction step of the aqueous phase to obtain the fourth organic phase

111‧‧‧對第三有機相進行第一矽膠管柱層析步驟,以獲得第一溶離液與殘留物之步驟111‧‧‧Step of performing a first xylene column chromatography step on the third organic phase to obtain the first eluent and residue

113‧‧‧合併殘留物與第四有機相,進行第二矽膠管柱層析步驟,以獲得含有牡丹皮萃取物之第二溶離液之步驟113‧‧‧ Combining the residue with the fourth organic phase, performing a second xylene column chromatography step to obtain a second eluate containing the peony bark extract

Claims (3)

一種於體外處理細胞之方法,其特徵在於利用含有一有效含量之如式(I)所示之牡丹皮苷D(mudanpioside D)之一組成物於體外處理一皮膚細胞或一黑色素細胞: 且該牡丹皮苷D兼具修復DNA與抑制黑色素生成的生物活性,以於體外修復該皮膚細胞之DNA並抑制該黑色素細胞之黑色素生成。A method for treating cells in vitro, characterized in that a skin cell or a melanocyte is treated in vitro by using an effective amount of a composition of mudanpioside D as shown in formula (I): Moreover, the peony saponin D has the biological activity of repairing DNA and inhibiting melanin production, thereby repairing DNA of the skin cells in vitro and inhibiting melanin production of the melanocytes. 根據申請專利範圍第1項所述之於體外處理細胞之方法,其中該組成物為一化妝品組合物及/或一食品添加物。 The method for treating cells in vitro according to the first aspect of the invention, wherein the composition is a cosmetic composition and/or a food additive. 根據申請專利範圍第1項所述之於體外處理細胞之方法,其中該皮膚細胞以及該黑色素細胞之一來源為人或小鼠。The method for treating cells in vitro according to claim 1, wherein the skin cells and one of the melanocytes are derived from human or mouse.
TW101137159A 2012-10-08 2012-10-08 Method of treating cells in vitro with composition containing extract of peony root cortex and application thereof TWI483742B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW101137159A TWI483742B (en) 2012-10-08 2012-10-08 Method of treating cells in vitro with composition containing extract of peony root cortex and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW101137159A TWI483742B (en) 2012-10-08 2012-10-08 Method of treating cells in vitro with composition containing extract of peony root cortex and application thereof

Publications (2)

Publication Number Publication Date
TW201414502A TW201414502A (en) 2014-04-16
TWI483742B true TWI483742B (en) 2015-05-11

Family

ID=53723462

Family Applications (1)

Application Number Title Priority Date Filing Date
TW101137159A TWI483742B (en) 2012-10-08 2012-10-08 Method of treating cells in vitro with composition containing extract of peony root cortex and application thereof

Country Status (1)

Country Link
TW (1) TWI483742B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108330156A (en) * 2018-03-26 2018-07-27 上海数儒生物科技有限公司 A kind of big white orchid growing point extract safety detecting method

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201212990A (en) * 2010-09-29 2012-04-01 Univ Chia Nan Pharm & Sciency Extracts from Peony's root cortex for application of skin whiteness and method of preparing the same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201212990A (en) * 2010-09-29 2012-04-01 Univ Chia Nan Pharm & Sciency Extracts from Peony's root cortex for application of skin whiteness and method of preparing the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Xu Shun-jun et al. "Rapid identification of compounds in Cortex Mountan by liquid chromatography-tandem mass spectrometry." Acta Pharmaceutica Sinica, 2006, Vol. 41(9), p. 852-856. *

Also Published As

Publication number Publication date
TW201414502A (en) 2014-04-16

Similar Documents

Publication Publication Date Title
Mao et al. Salidroside protects human fibroblast cells from premature senescence induced by H2O2 partly through modulating oxidative status
JP5872158B2 (en) Skin whitening method and screening method for skin spot formation inhibition and / or removal factor
US10092495B2 (en) Use of a composition comprising avocado perseose in the protection of epidermal stem cells
Lin et al. Optimal conditions for cordycepin production in surface liquid-cultured Cordyceps militaris treated with porcine liver extracts for suppression of oral cancer
Jeong et al. Modulation effects of sweroside isolated from the Lonicera japonica on melanin synthesis
Park et al. Synthesis of arbutin–gold nanoparticle complexes and their enhanced performance for whitening
Hseu et al. The anti-tumor activity of Antrodia salmonea in human promyelocytic leukemia (HL-60) cells is mediated via the induction of G1 cell-cycle arrest and apoptosis in vitro or in vivo
Lajis et al. Discovery of new depigmenting compounds and their efficacy to treat hyperpigmentation: Evidence from in vitro study
JP6460426B2 (en) Screening method for skin tone improver
Akbarpoor et al. The saffron effects on expression pattern of critical self-renewal genes in adenocarcinoma tumor cell line (AGS)
ES2622114T3 (en) Substance to restore normal coexpression and interaction between LOX and NRAGE proteins
Hong et al. Epimedium brevicornum Maxim. Extract exhibits pigmentation by melanin biosynthesis and melanosome biogenesis/transfer
Xu et al. 12-Deoxyphorbol 13-palmitate mediated cell growth inhibition, G2-M cell cycle arrest and apoptosis in BGC823 cells
JP6034921B1 (en) Phalaenopsis orchid extract, its preparation method and its application (THEACTIVE EXTRAACTOPPHALAENOPSIS, PREPARATIONMETHODANDSETHEREOF)
CN112089638B (en) Composition for inhibiting melanin synthesis
Li et al. Isokotomolide a from Cinnamomum kotoense induce melanoma autophagy and apoptosis in vivo and in vitro
TWI480047B (en) Extract of peony root cortex, method of preparing the same and application thereof
TWI483742B (en) Method of treating cells in vitro with composition containing extract of peony root cortex and application thereof
Shi et al. Acanthopanacis Cortex extract: A novel photosensitizer for head and neck squamous cell carcinoma therapy
JP6143167B2 (en) Microphthalmia-related transcription factor inhibitor, melanin production inhibitor, cosmetic composition and anticancer agent
Gokce et al. A. hierchuntica extract exacerbates genotoxic, cytotoxic, apoptotic and oxidant effects in B16F10 melanoma cells
Chiu et al. Mechanism and inhibitory effects of cactus (Opuntia dillenii) extract on melanocytes and its potential application for whitening cosmetics
TWI491402B (en) Acetophenone compound extracted from peony root cortex, method of preparing the same and tis application in dna repair
JP5942185B2 (en) Whitening composition and anticancer agent having melanin suppression and MITF suppression action
Prokofiev et al. Solid herbal extract of Primula veris L. improves morphofunctional condition of rats’ myocardium in chronic alcohol intoxication